Implicit viral Sepsis

AB1_SEPSIS_VIRAL_IMPL

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions AB1_SEPSIS_CONDITION	71805
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — A08\|A8[0-1]\|A8[3-9]\|A9[2-9]\|B0[0-9]\|B2[5-7]\|B3[34]\|B97\|J09\|J1[0-2]\|U04 Hospital discharge: ICD-9 — 0086[ABCX]\|04[4-9]\|05[0-7]\|06[0-6]\|072\|074\|075\|0780A\|0743A\|0785\|0786B\|0787X\|0788X\|0790A\|0791A\|0748X\|0793A\|0788D\|480\|487\|5738X\|7908A Cause of death: ICD-10 — A08\|A8[0-1]\|A8[3-9]\|A9[2-9]\|B0[0-9]\|B2[5-7]\|B3[34]\|B97\|J09\|J1[0-2]\|U04 Cause of death: ICD-9 — 0086[ABCX]\|04[4-9]\|05[0-7]\|06[0-6]\|072\|074\|075\|0780A\|0743A\|0785\|0786B\|0787X\|0788X\|0790A\|0791A\|0748X\|0793A\|0788D\|480\|487\|5738X\|7908A 2 out of 7 registries used, show all original rules.	11968
4. Check minimum number of events None	11968
5. Include endpoints None	11968
6. Filter based on genotype QC (FinnGen only)	10416

Control definitions (FinnGen only)

Control exclude: AB1_SEPSIS_EXPLICIT, AB1_SEPSIS_IMPLICIT

Extra metadata

First used in FinnGen datafreeze: DF8

NAME	AB1_SEPSIS_VIRAL_IMPL
CONTROL_EXCLUDE	AB1_SEPSIS_EXPLICIT\|AB1_SEPSIS_IMPLICIT
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS	AB1_SEPSIS_CONDITION
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	A08\|A8[0-1]\|A8[3-9]\|A9[2-9]\|B0[0-9]\|B2[5-7]\|B3[34]\|B97\|J09\|J1[0-2]\|U04
HD_ICD_9	0086[ABCX]\|04[4-9]\|05[0-7]\|06[0-6]\|072\|074\|075\|0780A\|0743A\|0785\|0786B\|0787X\|0788X\|0790A\|0791A\|0748X\|0793A\|0788D\|480\|487\|5738X\|7908A
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	A08\|A8[0-1]\|A8[3-9]\|A9[2-9]\|B0[0-9]\|B2[5-7]\|B3[34]\|B97\|J09\|J1[0-2]\|U04
COD_ICD_9	0086[ABCX]\|04[4-9]\|05[0-7]\|06[0-6]\|072\|074\|075\|0780A\|0743A\|0785\|0786B\|0787X\|0788X\|0790A\|0791A\|0748X\|0793A\|0788D\|480\|487\|5738X\|7908A
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Implicit viral Sepsis based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	10416	5226	5190
Unadjusted period prevalence (%)	2.12	1.86	2.38
Median age at first event (years)	64.76	62.18	67.36

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
10779: Matched controls
107789

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

TPH07

NOMESCO Finland

Cathetrisation of artery

2.9

323.0

1733

6610

N05AH04

ATC

quetiapine; oral

2.6

322.8

2316

10259

B07.9

ICD-10 Finland

Verruca simplex

4.8

322.8

760

1666

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

5.4

321.8

655

1266

R02

ICPC

Shortness of breath/dyspnoea

2.7

321.0

2093

8842

A86

ICD-10 Finland

Unspecified viral encephalitis

22.5

319.8

234

106

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

6.6

318.7

530

843

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

4.1

315.0

929

2426

B05DA

ATC

Isotonic solutions

18.9

314.1

248

134

XA800

NOMESCO Finland

Neuropsychological investigation

5.0

312.7

704

1486

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.9

312.4

1736

6742

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

2.3

309.8

3162

16392

A08.1

ICD-10 Finland

Acute gastroenteropathy due to Norovirus

28.0

309.8

209

H02AB04

ATC

methylprednisolone; systemic

2.7

307.8

1981

8300

A49.9

ICD-10 Finland

Bacterial infection, unspecified

5.3

307.7

2444

5673

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

370.1

307.7

725

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.7

307.7

4167

20441

I46.0

ICD-10 Finland

Cardiac arrest with successful resuscitation

17.1

307.7

370

224

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

3.9

307.7

1670

4835

ZXD05

NOMESCO Finland

Urgent procedure

2.3

307.7

3742

20255

A28

ICPC

Limited function/disability NOS

2.9

307.7

3085

13054

V03AE01

ATC

polystyrene sulfonate; oral

10.5

307.7

389

383

J12.8

ICD-10 Finland

Other viral pneumonia

15.4

307.7

412

277

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

5.0

307.7

1288

2873

L28

ICPC

Limited function/disability (L)

2.5

307.7

2887

13582

TK800

NOMESCO Finland

Hemodialysis

20.3

307.7

765

404

A10AB05

ATC

insulin aspart; parenteral

3.9

307.7

1356

3793

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

4.4

307.7

3856

12092

127

Kela drug reimbursment

Transplant complication

27.5

307.7

714

277

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

11.2

307.7

3122

3800

N18.0

ICD-10 Finland

End-stage renal disease

16.4

307.7

330

207

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

12.0

307.7

703

621

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.2

307.7

4509

26264

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

28.8

307.7

370

133

R55

ICD-10 Finland

Syncope and collapse

24.1

307.7

4460

3072

WX892

NOMESCO Finland

Monitored bed care

4.1

307.7

1387

3718

R42

ICD-10 Finland

Dizziness and giddiness

2.4

307.7

3363

16846

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.7

307.7

2334

10074

J05AB11

ATC

valaciclovir; oral

2.8

307.7

2134

8867

L04AD02

ATC

tacrolimus; systemic

27.5

307.7

451

171

R03BB04

ATC

tiotropium bromide; inhalant

3.1

307.7

1589

5691

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.7

307.7

2350

9933

TK810

NOMESCO Finland

Hemofiltration

27.6

307.7

222

C03CA01

ATC

furosemide; systemic

3.7

307.7

5489

23705

R11

ICD-10 Finland

Nausea and vomiting

3.8

307.7

1647

4918

B03XA02

ATC

darbepoetin alfa; parenteral

9.4

307.7

556

620

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.7

307.7

2749

12192

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

4.7

307.7

822

1851

I50.9

ICD-10 Finland

Heart failure, unspecified

3.5

307.7

2755

9740

I95.9

ICD-10 Finland

Hypotension, unspecified

15.3

307.7

449

306

J01MA14

ATC

moxifloxacin; systemic

3.4

307.7

1400

4537

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

4.7

307.7

2378

6118

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

3.1

307.7

1561

5531

J12.1

ICD-10 Finland

Respiratory syncytial virus pneumonia

18.0

307.7

288

164

B34.9

ICD-10 Finland

Viral infection, unspecified

8.0

307.7

883

1186

J01MA12

ATC

levofloxacin; systemic

2.8

307.7

2672

11425

R50.9

ICD-10 Finland

Fever, unspecified

4.2

307.7

2939

8796

JN3AD

NOMESCO Finland

Abdominal CT examination

3.1

307.7

2048

7532

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

4.2

307.7

1393

3687

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

13.8

307.7

762

590

XF400

NOMESCO Finland

ECG with 12 standard connections

2.7

307.7

2327

9847

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

31.7

307.7

311

101

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

5.0

307.7

1508

3418

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

3.8

307.7

2353

7466

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

20.3

307.7

248

125

J01MA02

ATC

ciprofloxacin; systemic

2.2

307.7

4877

29062

N17.9

ICD-10 Finland

Acute renal failure, unspecified

62.0

307.7

1939

380

TPH04

NOMESCO Finland

Cathetrisation of vein

3.0

307.7

3410

14305

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.7

307.7

2757

12148

H02AB06

ATC

prednisolone; systemic

2.6

307.7

6164

36697

C07AB07

ATC

bisoprolol; oral

2.5

307.7

6430

40352

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.3

307.7

4312

24110

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

15.3

307.7

833

588

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

3.6

307.7

3108

11000

A46

ICD-10 Finland

Erysipelas

2.9

307.7

2230

9036

L04AA06

ATC

mycophenolic acid; systemic

18.3

307.7

767

449

R53

ICD-10 Finland

Malaise and fatigue

2.8

307.7

3809

17642

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.3

307.7

4481

25065

N02AX02

ATC

tramadol; systemic, rectal

2.3

307.7

5325

32584

J45.9

ICD-10 Finland

Asthma, unspecified

2.5

307.7

2591

12043

R03AC02

ATC

salbutamol; inhalant

2.2

307.7

6327

42412

R40.2

ICD-10 Finland

Coma, unspecified

26.8

307.7

257

A02BC02

ATC

pantoprazole; systemic

2.5

307.7

8025

57716

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

4.8

307.7

3506

9820

A41.8

ICD-10 Finland

Other specified sepsis

233.3

307.7

339

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

8.5

307.7

1180

1532

B02.9

ICD-10 Finland

Zoster without complication

5.0

307.7

1726

3968

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

13.8

307.7

394

295

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

16.0

307.7

1698

1248

J18.9

ICD-10 Finland

Pneumonia, unspecified

4.2

307.7

4917

18116

N18.8

ICD-10 Finland

Other chronic renal failure

7.5

307.7

606

855

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

3.6

307.7

1372

4189

Z49.1

ICD-10 Finland

Extracorporeal dialysis

24.8

307.7

487

205

A12AA04

ATC

calcium carbonate; oral

12.2

307.7

451

383

R51.80

ICD-10 Finland

Headache

2.9

307.7

2214

8867

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

21.2

307.7

371

181

A11CC03

ATC

alfacalcidol; systemic

9.4

307.7

640

717

A41.9

ICD-10 Finland

Sepsis, unspecified

143.4

307.7

785

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

29.1

307.7

264

R56.8

ICD-10 Finland

Other and unspecified convulsions

4.6

307.7

897

2069

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

7.2

307.7

589

857

N03AX16

ATC

[U] pregabalin

2.6

307.7

3133

14667

R07.4

ICD-10 Finland

Chest pain, unspecified

2.3

307.7

3778

20743

I50.0

ICD-10 Finland

Congestive heart failure

3.6

307.7

1440

4416

AA1AD

NOMESCO Finland

CT of head and brain

3.8

307.7

5119

20642

A98.5

ICD-10 Finland

Haemorrhagic fever with renal syndrome

9.2

307.7

616

707

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.9

307.7

2525

7751

J96.1

ICD-10 Finland

Chronic respiratory failure

69.9

307.7

845

131

N17.0

ICD-10 Finland

Acute renal failure with tubular necrosis

73.1

307.7

201

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.9

307.7

7289

37658

R06.0

ICD-10 Finland

Dyspnoea

2.9

307.7

4158

19405

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

16.2

307.7

594

386

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

3.0

307.7

2414

9339

137

Kela drug reimbursment

Uraemia requiring dialysis

21.2

307.7

312

151

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.6

307.7

3419

16446

N02AA05

ATC

oxycodone; systemic

2.7

307.7

2814

12645

L04AD01

ATC

ciclosporin; systemic

10.5

307.7

506

503

J96.0

ICD-10 Finland

Acute respiratory failure

73.3

307.7

497

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

26.9

307.7

324

124

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

348.6

307.7

435

ZX120

NOMESCO Finland

Intravenous

3.2

307.7

1447

4912

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

5.2

307.7

964

2012

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

5.7

307.7

1319

2566

Z94.0

ICD-10 Finland

Kidney transplant status

26.1

307.7

478

191

N17.8

ICD-10 Finland

Other acute renal failure

65.2

307.7

516

E86

ICD-10 Finland

Volume depletion

6.5

307.7

567

907

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

27.1

307.6

210

L04AX01

ATC

azathioprine; systemic

4.7

306.0

749

1694

N03AX12

ATC

[U] gabapentin; oral

2.6

305.6

2154

9436

V03AE02

ATC

sevelamer; oral

28.9

305.4

204

Z49.2

ICD-10 Finland

Other dialysis

19.2

305.0

239

127

J96.9

ICD-10 Finland

Respiratory failure, unspecified

32.5

303.2

195

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

3.2

302.4

1365

4710

C03DA01

ATC

spironolactone; oral

2.7

302.3

1881

7741

Z49.0

ICD-10 Finland

Preparatory care for dialysis

13.3

298.2

284

219

WX872

NOMESCO Finland

Intensive care

4.1

297.3

865

2234

J05AB01

ATC

aciclovir; systemic

2.3

296.6

2858

14416

D64.9

ICD-10 Finland

Anaemia, unspecified

2.8

293.1

1746

7018

Z2446

NOMESCO Finland

Social worker

3.7

292.9

1018

2978

Z01.8

ICD-10 Finland

Other specified special examinations

2.3

291.5

2953

15199

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.6

288.2

1944

8315

SPAT1254

SPAT

Administration of medicine

2.5

287.9

2233

10208

A10AE04

ATC

insulin glargine; parenteral

3.0

287.0

1442

5284

N06AX11

ATC

mirtazapine; oral

2.1

286.8

4104

24211

A06AD11

ATC

lactulose; oral

2.5

286.0

2208

10069

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

2.4

286.0

2384

11260

J01FF01

ATC

clindamycin; systemic

2.2

284.1

3242

17496

S97

ICPC

Chronic ulcer skin

3.5

283.2

1066

3284

J01DB01

ATC

cefalexin; oral

2.6

281.7

9130

73294

A10AC01

ATC

insulin (human); parenteral

3.3

281.2

1179

3885

TPX10

NOMESCO Finland

Implantation of vascular injection port

5.6

280.7

546

1011

R4110

NOMESCO Finland

Physiotherapy

2.2

278.0

3441

19150

B05DB

ATC

Hypertonic solutions

18.5

276.2

220

121

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.8

275.9

1639

6564

J11.1

ICD-10 Finland

Influenza with other respiratory manifestations, virus not identified

6.5

271.2

454

726

UJF32

NOMESCO Finland

Coloscopy

2.2

268.2

3326

18475

M04AA01

ATC

allopurinol; systemic

2.6

267.7

1917

8415

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

4.2

267.0

760

1928

E87.5

ICD-10 Finland

Hyperkalaemia

7.0

267.0

416

617

L04AA01

ATC

[U] ciclosporin

9.3

266.4

325

361

Z3231

NOMESCO Finland

Registered nurse

2.1

265.1

3425

19312

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

11.1

264.5

283

262

N19

ICD-10 Finland

Unspecified kidney failure

4.4

263.2

696

1670

UGC12

NOMESCO Finland

Flexible bronchoscopy

3.1

262.8

1231

4324

E87.2

ICD-10 Finland

Acidosis

50.7

260.8

150

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

2.0

259.7

5777

39523

H02AB09

ATC

hydrocortisone; systemic

5.9

259.3

474

827

196

Kela drug reimbursment

Paricalcitol and cinacalcet

27.8

258.7

175

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

3.0

257.3

1308

4809

N03AG01

ATC

valproic acid; systemic, rectal

3.7

257.1

884

2561

S06.0

ICD-10 Finland

Concussion

2.7

256.8

1562

6317

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

3.6

255.6

898

2639

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

3.4

255.2

977

3036

B01AA03

ATC

warfarin; systemic

2.2

255.1

2677

13872

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

3.2

254.0

1094

3655

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

4.9

253.5

580

1238

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

3.0

253.4

1234

4428

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

3.6

253.1

896

2646

N05BA04

ATC

oxazepam; oral

2.1

252.0

3215

17978

I95.1

ICD-10 Finland

Orthostatic hypotension

4.1

250.5

732

1892

A04

ICPC

Weakness/tiredness general

2.3

250.3

2251

10924

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.5

249.2

1850

8237

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.7

247.0

1584

6571

JN4AD

NOMESCO Finland

Body CT examination

2.6

246.6

1604

6700

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.8

246.0

1444

5727

TAB00

NOMESCO Finland

Lumbar puncture

4.2

243.3

672

1665

I25.1

ICD-10 Finland

Atherosclerotic heart disease

2.1

238.1

3100

17404

GD1AD

NOMESCO Finland

Thorax CT examination

3.3

237.9

993

3251

B25.8

ICD-10 Finland

Other cytomegaloviral diseases

34.3

235.5

149

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

3.0

232.4

1153

4172

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.3

232.4

2118

10303

WX408

NOMESCO Finland

General anesthesy, balanced

2.1

232.3

3033

17019

N06AX21

ATC

duloxetine; oral

2.6

232.2

1490

6171

ZX108

NOMESCO Finland

Inhalation

13.4

232.2

219

166

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

12.9

231.6

224

177

215

Kela drug reimbursment

Diabetes, non-insulin-treated

2.1

231.4

3031

17024

WX730

NOMESCO Finland

Conventional respirator

7.9

230.3

320

417

WX882

NOMESCO Finland

High dependency care

5.0

229.8

515

1079

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

4.1

228.0

651

1652

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

3.8

226.0

734

2042

N02BE01

ATC

paracetamol; systemic, rectal

2.8

224.8

9773

83404

SPAT1262

SPAT

Handing over of treatment supplies

2.2

224.4

2238

11286

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

3.5

223.6

839

2568

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

15.9

223.4

192

123

N06AX16

ATC

venlafaxine; oral

2.5

223.3

1608

7031

WX725

NOMESCO Finland

Noninvasive ventilation

3.5

223.1

809

2422

KA1AE

NOMESCO Finland

Kidney ultrasound examination

5.3

222.9

463

908

C08CA01

ATC

amlodipine; oral

1.9

222.8

4694

30993

KA9AE

NOMESCO Finland

Ultrasound examination transplanted kidney

31.7

222.3

144

N05CF01

ATC

zopiclone; oral

2.0

222.0

3825

23615

N30.0

ICD-10 Finland

Acute cystitis

2.2

221.9

2184

10949

A07AA09

ATC

vancomycin; oral

7.5

221.1

320

437

T36

ICD-10 Finland

Poisoning by systemic antibiotics

4.3

220.8

593

1437

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.8

220.7

1233

4752

SPAT1263

SPAT

Sampling

1.9

220.3

4815

32138

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

3.5

219.5

796

2383

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

5.9

218.1

402

706

J80

ICD-10 Finland

Adult respiratory distress syndrome

66.8

217.5

119

SPAT1255

SPAT

Intravenous administration of medicine

3.1

215.2

969

3313

XF600

NOMESCO Finland

Bloodpressure measurement

3.1

214.0

971

3334

J12.9

ICD-10 Finland

Viral pneumonia, unspecified

12.0

213.1

216

184

G40.9

ICD-10 Finland

Epilepsy, unspecified

4.4

212.2

550

1296

H19.1*B00.5

ICD-10 Finland

Herpesviral keratoconjunctivitis

8.9

212.2

265

303

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

24.5

212.2

150

Z3226

NOMESCO Finland

Physiotherapist

2.2

212.1

2200

11244

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

42.5

210.6

126

S01AD03

ATC

aciclovir; ophthalmic

4.0

210.4

621

1613

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

7.3

209.5

310

434

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

3.3

209.4

832

2637

B01AC04

ATC

clopidogrel; oral

2.2

208.4

2264

11776

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

11.8

208.2

213

184

C01DA14

ATC

isosorbide mononitrate; oral

2.2

208.0

2283

11922

XG466

NOMESCO Finland

Sleep oxymetry

4.7

206.9

493

1086

SPAT1301

SPAT

No procedures

1.9

205.4

3796

23848

B25.9

ICD-10 Finland

Cytomegaloviral disease, unspecified

30.8

205.1

134

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.9

204.8

1076

4007

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.6

204.1

1336

5568

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.7

203.6

1177

4609

XF404

NOMESCO Finland

Ambulatory ECG

2.7

203.3

1202

4761

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

17.4

202.3

166

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.1

201.5

2372

12706

K72.0

ICD-10 Finland

Acute and subacute hepatic failure

52.8

201.5

115

N05BA01

ATC

diazepam; systemic, rectal

2.4

201.3

1633

7513

B01AB05

ATC

enoxaparin; parenteral

1.9

200.9

3643

22707

I48

ICD-10 Finland

Atrial fibrillation and flutter

2.0

200.9

2901

16740

N03AX09

ATC

lamotrigine; oral

3.8

199.9

632

1723

SPAT1216

SPAT

Assessment of functional ability

2.2

199.2

2110

10846

K72.9

ICD-10 Finland

Hepatic failure, unspecified

28.6

198.8

133

TGC00

NOMESCO Finland

Bronchial lavation

4.7

198.7

473

1041

FPK00

NOMESCO Finland

Implantation of electrocardiograph with loop recorder

16.9

198.5

165

AN1

Coronary angiography

2.4

197.4

1553

7045

103

Kela drug reimbursment

Diabetes, insulin-treated

1.9

196.6

3273

19805

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

3.4

196.2

735

2243

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

3.0

196.2

945

3352

R40.0

ICD-10 Finland

Somnolence

40.1

196.1

119

Z94.1

ICD-10 Finland

Heart transplant status

48.0

195.8

114

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

8.8

195.6

248

289

R60.0

ICD-10 Finland

Localized oedema

2.3

194.9

1723

8220

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

11.2

193.3

205

187

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

4.1

193.1

557

1422

N05AH03

ATC

olanzapine; systemic

3.2

192.0

816

2691

V03AE03

ATC

lanthanum carbonate; oral

24.8

191.9

135

J46

ICD-10 Finland

Status asthmaticus

4.5

191.7

482

1108

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

3.4

191.6

720

2201

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.8

190.9

4717

32269

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.9

189.6

3203

19432

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.6

189.0

651

1880

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.5

188.9

1291

5482

A10AE05

ATC

insulin detemir; parenteral

3.3

188.5

764

2448

A02BC01

ATC

omeprazole; systemic

1.9

188.3

3223

19630

NA1AD

NOMESCO Finland

Cervical spine CT examination

3.4

188.1

728

2267

X59

ICD-10 Finland

Exposure to unspecified factor

2.1

186.5

2263

12218

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.8

185.8

5035

35316

D69.5

ICD-10 Finland

Secondary thrombocytopenia

61.2

185.4

103

B03XA01

ATC

erythropoietin; parenteral

9.6

185.2

219

233

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

3.0

184.4

880

3102

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.8

180.1

4531

30999

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.9

179.6

2943

17618

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.9

179.5

907

3299

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

3.4

178.6

690

2145

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

6.9

178.3

279

415

N03AF02

ATC

oxcarbazepine; oral

4.1

178.1

507

1281

A03

ICPC

Fever

2.1

177.6

1991

10415

J01CA04

ATC

amoxicillin; systemic

2.0

175.6

8666

72307

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.5

175.3

1217

5197

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

5.8

174.2

321

563

TKC20

NOMESCO Finland

Catheterisation of bladder

2.8

173.4

953

3623

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.0

173.3

2220

12188

S18

ICPC

Laceration/cut

1.8

171.9

5303

38315

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.6

171.2

1126

4684

N06AB04

ATC

citalopram; systemic

2.0

171.1

2289

12757

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.8

170.7

945

3606

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.0

170.7

2201

12106

XW000

NOMESCO Finland

Bone marrow biopsy

3.5

170.6

621

1858

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.2

169.7

1575

7634

Z94.4

ICD-10 Finland

Liver transplant status

22.4

169.3

124

A07AA02

ATC

nystatin; oral

2.9

169.1

847

3063

ZXE10

NOMESCO Finland

More than one and less than three hours

1.8

168.9

3885

25756

SPAT1229

SPAT

Assessment of need for aid

2.6

168.8

1065

4341

J01AA02

ATC

doxycycline; systemic

1.9

168.0

8129

66742

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

2.3

167.9

1386

6392

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

3.1

167.9

762

2607

N02AJ06

ATC

codeine and paracetamol; systemic

1.8

167.2

4543

31580

M79.6

ICD-10 Finland

Pain in limb

1.7

166.4

4736

33343

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.1

166.4

2022

10873

M10.9

ICD-10 Finland

Gout, unspecified

2.7

165.6

993

3945

H02AB07

ATC

prednisone; oral

2.2

165.1

1605

7921

A87.9

ICD-10 Finland

Viral meningitis, unspecified

10.9

163.6

176

164

WX002

NOMESCO Finland

Sedation and analgesia

2.0

163.2

2252

12663

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

29.5

162.9

108

WW500

NOMESCO Finland

Blood transfusion

3.5

161.3

574

1691

WW200

NOMESCO Finland

Immunization

4.3

161.0

431

1039

N05AX08

ATC

risperidone; systemic

2.5

160.2

1169

5098

PBL09

NOMESCO Finland

Construction of arteriovenous fistula from brachial artery

36.0

160.2

100

P20

ICPC

Memory disturbance

2.1

160.1

1946

10450

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.7

159.7

897

3445

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

4.4

159.2

413

972

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.8

158.9

3468

22543

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

3.8

158.6

509

1399

G47.3

ICD-10 Finland

Sleep apnoea

1.9

158.5

2461

14383

H05BX01

ATC

cinacalcet; oral

11.6

158.4

163

142

W19

ICD-10 Finland

Unspecified fall

2.3

158.3

1315

6073

A01

ICPC

Pain general/multiple sites

2.3

157.8

1329

6173

R41.0

ICD-10 Finland

Disorientation, unspecified

3.7

157.7

520

1456

A08.3

ICD-10 Finland

Other viral enteritis

13.8

157.7

146

107

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

8.0

157.5

215

274

Z2445

NOMESCO Finland

Psychologist

3.7

157.5

511

1415

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

13.9

156.8

145

106

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

4.3

156.3

418

1007

J01FA06

ATC

roxithromycin; oral

1.7

155.7

4117

28238

B99

ICD-10 Finland

Other and unspecified infectious diseases

5.1

155.4

333

670

WX110

NOMESCO Finland

Infiltration anesthesia

1.8

154.9

7428

59940

R33

ICD-10 Finland

Retention of urine

2.5

154.7

1105

4769

C09AA05

ATC

ramipril; oral

1.8

154.3

2997

18782

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.8

153.9

857

3275

K59.09

ICD-10 Finland

Constipation, unspecified

2.6

153.5

989

4065

UKC02

NOMESCO Finland

Cystoscopy

2.0

153.1

2031

11236

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.5

153.1

1091

4703

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

5.9

152.9

280

488

A02BC05

ATC

esomeprazole; systemic

1.7

152.7

4292

29897

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

2.4

152.5

1195

5375

Z94.2

ICD-10 Finland

Lung transplant status

39.1

152.2

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

12.6

152.2

149

120

E0000UV, ,

ATC

1.7

152.1

4515

31914

H3603, E103,

ICD-10 Finland

8.9

151.8

189

215

J10.8

ICD-10 Finland

Influenza with other manifestations, seasonal influenza virus identified

19.7

151.4

117

TK820

NOMESCO Finland

Peritoneal dialysis

15.1

151.1

133

SPAT1260

SPAT

Consultation of another employee

2.0

151.1

2091

11733

J45.1

ICD-10 Finland

Nonallergic asthma

2.6

151.0

940

3799

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.5

150.8

1055

4507

N06AA09

ATC

amitriptyline; systemic

2.4

150.7

1143

5067

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.9

150.5

760

2756

ZXE20

NOMESCO Finland

More than three and less than five hours

2.1

150.3

1573

7971

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

3.0

149.9

692

2387

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.2

149.5

1406

6828

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

4.0

149.3

436

1121

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.6

149.0

943

3840

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.0

148.9

2030

11325

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

19.7

148.8

115

I10

ICD-10 Finland

Essential (primary) hypertension

1.7

148.7

6813

53953

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

10.0

148.5

170

173

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

3.4

148.4

568

1752

205

Kela drug reimbursment

Chronic hypertension

1.8

147.8

3252

21096

M54.5

ICD-10 Finland

Low back pain

1.7

147.7

3859

26281

N05AA02

ATC

levomepromazine; systemic

3.5

147.4

524

1542

R4190

NOMESCO Finland

Nutritional therapy

3.4

147.3

548

1660

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.8

146.3

770

2854

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

6.1

146.1

258

434

Z3229

NOMESCO Finland

Other healthcare associate professional

2.4

145.7

1098

4849

N06AB10

ATC

escitalopram; oral

1.9

145.3

2078

11773

A10AB01

ATC

insulin (human); parenteral

3.7

145.3

480

1345

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.1

144.7

1697

8965

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

3.0

144.5

698

2469

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.5

144.1

1018

4365

Z2221

NOMESCO Finland

Medical doctor

1.8

144.1

2903

18327

WZC00

NOMESCO Finland

Treatment plan or consultation

1.7

143.3

4030

27944

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.8

143.0

742

2729

I50.1

ICD-10 Finland

Left ventricular failure

2.9

142.6

724

2632

G93.4

ICD-10 Finland

Encephalopathy, unspecified

61.2

142.1

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.7

142.0

807

3112

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.3

141.5

1237

5822

C07AB02

ATC

metoprolol; systemic

1.9

140.7

2444

14731

XG410

NOMESCO Finland

Flow-volume spirometry

3.3

140.5

555

1745

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

6.1

139.4

244

407

N05CD07

ATC

temazepam; oral

2.1

138.9

1429

7178

N02BF02

ATC

pregabalin; oral

2.6

138.9

859

3456

T90

ICPC

Diabetes non-insulin dependent

1.8

138.3

2775

17463

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

3.0

137.5

651

2276

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.8

137.2

3059

19838

R03BA05

ATC

fluticasone; inhalant

1.9

136.8

1983

11261

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

3.1

136.8

619

2109

A29

ICPC

General symptom/complaint other

2.0

136.7

1694

9114

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

15.4

136.7

119

P01AB01

ATC

metronidazole; oral, rectal

1.7

134.9

3924

27341

N30.9

ICD-10 Finland

Cystitis, unspecified

2.6

134.9

858

3498

A10BH05

ATC

linagliptin; oral

2.8

134.8

741

2807

ZXE00

NOMESCO Finland

One hour or less

1.7

134.7

4021

28206

N03AE01

ATC

clonazepam; systemic

2.8

134.4

719

2686

J01DA01

ATC

[U] cefalexin

1.7

134.3

6265

49206

R5140

NOMESCO Finland

Monitoring the use of the aid

2.2

134.3

1273

6186

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.1

134.1

1500

7771

B01AF02

ATC

apixaban; oral

2.0

134.0

1750

9586

N03AX14

ATC

levetiracetam; systemic

3.8

133.5

424

1156

JN4BD

NOMESCO Finland

Extensive body CT

2.2

133.4

1233

5930

ZXA00

NOMESCO Finland

Right side

1.8

133.2

2909

18725

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.2

133.0

1303

6414

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

3.1

132.8

595

2015

I20.99

ICD-10 Finland

Angina pectoris, unspecified

2.5

132.7

912

3856

SPAT1234

SPAT

Support of social functional capacity

2.7

132.2

752

2899

ZY010

NOMESCO Finland

Hospital outpatient

3.0

132.0

627

2195

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

656.3

131.8

130

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.5

131.6

861

3556

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

2.3

131.6

1079

4935

L89

ICD-10 Finland

Decubitus ulcer and pressure area

4.7

131.6

309

671

EBA15

NOMESCO Finland

Extraction of multiple teeth

3.2

131.3

552

1801

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

3.3

130.4

522

1654

J01EA01

ATC

trimethoprim; systemic

1.8

129.3

2765

17666

J11.0

ICD-10 Finland

Influenza with pneumonia, virus not identified

11.4

128.6

134

119

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

3.9

128.3

382

995

321

Kela drug reimbursment

Paricalcitol and cinacalcet

9.9

127.5

147

151

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.7

127.0

741

2892

A40.8

ICD-10 Finland

Other streptococcal sepsis

320.9

126.7

128

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.8

126.2

2433

15069

207

Kela drug reimbursment

Chronic arrhythmias

1.9

126.1

2010

11742

Z71.8

ICD-10 Finland

Other specified counselling

1.7

125.9

3586

24740

X58

ICD-10 Finland

Exposure to other specified factors

2.0

125.8

1621

8820

H19.2*B02.3

ICD-10 Finland

Keratitis and keratoconjunctivitis (interstitial) in zoster

10.1

125.6

142

B02.8

ICD-10 Finland

Zoster with other complications

7.5

125.0

180

244

F05.9

ICD-10 Finland

Delirium, unspecified

4.0

125.0

361

920

A03FA01

ATC

metoclopramide; systemic, rectal

1.8

124.4

2358

14523

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

4.3

123.5

328

785

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

3.5

123.3

430

1248

A02BC03

ATC

lansoprazole; oral

1.7

123.0

3016

19971

C10AA01

ATC

simvastatin; oral

1.6

122.9

4699

34843

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.2

122.1

1194

5862

E87.6

ICD-10 Finland

Hypokalaemia

3.3

121.4

486

1539

K92.1

ICD-10 Finland

Melaena

2.6

121.4

738

2939

L17

ICPC

Foot/toe symptom/complaint

1.7

121.1

3360

22971

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

3.2

121.1

504

1634

JJC00

NOMESCO Finland

Allogenic transplantation of liver

25.6

120.8

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.8

120.8

2245

13729

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

3.0

120.6

572

1999

T89

ICPC

Diabetes insulin dependent

3.2

120.5

496

1597

R95

ICPC

Chron obstructive pulmonary disease

3.4

119.3

436

1304

NHQ40

NOMESCO Finland

Amputation of toe

4.8

119.2

270

569

A10AB04

ATC

insulin lispro; parenteral

3.7

119.1

391

1090

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.8

119.0

2322

14397

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.8

118.9

630

2338

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.0

118.9

1385

7260

N06AB06

ATC

sertraline; oral

2.1

118.5

1189

5894

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.2

118.1

1139

5558

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

11.4

117.3

122

108

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

2.9

117.2

584

2097

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.9

117.0

584

2099

N05AX12

ATC

aripiprazole; systemic

3.3

116.9

448

1381

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

3.7

116.8

376

1034

TQW11

NOMESCO Finland

Vacuum treatment of wound

4.4

116.7

299

696

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

4.4

116.6

295

680

GDG10

NOMESCO Finland

Bilateral transplantation of lung

39.7

116.5

R52.2

ICD-10 Finland

Other chronic pain

3.1

116.4

500

1651

PG5AC

NOMESCO Finland

Contrast examination of injection gate to artery or vein

41.4

116.1

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.3

115.7

929

4202

A06AC01

ATC

ispaghula (psylla seeds); oral

1.7

115.7

2855

18882

J45.8

ICD-10 Finland

Mixed asthma

3.4

114.6

425

1283

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.8

114.4

2068

12518

348

Kela drug reimbursment

Roflumilast

18.9

114.3

I20.09

ICD-10 Finland

Unstable angina

2.5

114.3

775

3250

C02AC05

ATC

moxonidine; oral

2.8

114.2

621

2336

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.9

114.1

570

2049

R06AE07

ATC

cetirizine; oral

1.6

113.7

4331

31902

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

3.4

113.5

418

1256

C10AA05

ATC

atorvastatin; oral

1.6

113.0

4579

34206

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

4.2

112.9

310

761

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

112.5

1555

8640

K59.1

ICD-10 Finland

Functional diarrhoea

2.6

112.2

719

2935

SAA03

NOMESCO Finland

Extended examination of mouth

1.6

111.9

3912

28199

WX721

NOMESCO Finland

Oxygen concentrator therapy

25.3

111.7

XF402

NOMESCO Finland

ECG with work load test

2.1

111.4

1226

6286

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.4

111.3

815

3538

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

4.2

111.3

304

743

R03DC03

ATC

montelukast; oral

1.9

111.2

1673

9557

RS221, ,

NOMESCO Finland

5.3

111.0

224

427

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.0

110.6

1440

7838

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

3.0

110.6

518

1797

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.3

110.5

935

4322

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.7

109.7

3017

20474

N03AF01

ATC

carbamazepine; oral, rectal

2.7

109.6

614

2344

G44.2

ICD-10 Finland

Tension-type headache

2.0

109.6

1423

7736

J01CF05

ATC

flucloxacillin; systemic

2.4

109.6

820

3594

R52.9

ICD-10 Finland

Pain, unspecified

2.1

109.4

1202

6157

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

3.2

109.4

444

1417

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

5.9

109.2

199

345

ZXA05

NOMESCO Finland

Left side

1.7

109.0

2630

17244

R03BA02

ATC

budesonide; inhalant

1.8

108.9

1868

11111

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.7

108.1

2907

19600

Z51.5

ICD-10 Finland

Palliative care

2.1

108.0

1121

5620

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

6.7

107.7

171

258

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.6

107.4

4355

32416

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

6.7

107.3

170

256

R05

ICPC

Cough

1.7

107.3

2670

17638

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

3.0

107.1

486

1656

Z02.7

ICD-10 Finland

Issue of medical certificate

2.3

107.0

922

4292

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.5

106.9

737

3112

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

2.4

106.8

799

3501

5AB14, ,

NOMESCO Finland

27.9

106.6

WX722

NOMESCO Finland

PEEP

2.8

106.4

549

2007

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

3.4

105.9

396

1201

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.6

105.8

3877

28164

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.8

105.2

558

2070

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.9

105.2

530

1913

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

3.0

105.1

472

1598

R31

ICD-10 Finland

Unspecified haematuria

2.0

105.1

1262

6670

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

2.1

104.8

1045

5155

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.9

104.8

311

808

J02AC01

ATC

fluconazole; systemic

1.6

104.6

3512

24973

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

7.7

104.5

147

194

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

3.3

104.4

402

1242

PBU84

NOMESCO Finland

Plastic repair of arteriovenous fistula from artery of upper extremity

47.2

104.2

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

3.7

103.6

338

938

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.4

103.4

728

3102

R03DA04

ATC

theophylline; systemic, rectal

2.6

103.3

650

2628

SPAT1240

SPAT

Therapeutic discussion

2.1

103.2

1033

5102

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

3.0

103.1

464

1573

ZXA10

NOMESCO Finland

Bilateral

1.8

103.0

2060

12799

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

3.4

103.0

382

1153

ZXE40

NOMESCO Finland

More than seven and less than nine hours

3.8

102.9

323

873

R07.3

ICD-10 Finland

Other chest pain

2.0

102.8

1205

6311

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

4.0

102.2

293

742

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

3.3

102.2

395

1223

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

4.0

102.1

301

778

UJF30

NOMESCO Finland

Ileoscopy through colon

2.0

101.4

1141

5888

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

3.0

101.1

469

1617

H03.1*B02.3

ICD-10 Finland

Zoster blepharitis

9.5

100.9

119

126

N05BA06

ATC

lorazepam; systemic, sublingual

2.6

100.9

629

2531

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

6.9

100.8

155

226

R41.3

ICD-10 Finland

Other amnesia

3.2

100.8

411

1315

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

4.7

100.2

233

502

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

2.3

100.1

780

3476

E66.00

ICD-10 Finland

Metabolic syndrome

2.6

99.9

609

2424

P29

ICPC

Psychological sympt/compl other

2.3

99.6

783

3503

WX402

NOMESCO Finland

General anaesthesia

1.7

99.5

2234

14315

7802X

ICD-9 Finland

General symptoms, Syncope and collapse[SYNCOPE ET COLLAPSUS NUD]

+∞

99.1

201

Kela drug reimbursment

Chronic cardiac insufficiency

2.4

98.7

755

3337

R03DX07

ATC

roflumilast; oral

18.7

98.6

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

5.0

98.4

213

432

B02.3

ICD-10 Finland

Zoster ocular disease

9.1

98.3

120

133

H26.3

ICD-10 Finland

Drug-induced cataract

8.8

98.2

123

141

R60.9

ICD-10 Finland

Oedema, unspecified

2.4

98.1

715

3093

ZYC01

NOMESCO Finland

Remote contact by phone

2.4

97.8

728

3179

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

8.8

97.7

123

142

R5110, ,

SPAT

2.1

97.5

1045

5292

N17

ICPC

Vertigo/dizziness

1.9

97.5

1527

8804

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

4.4

97.3

249

579

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.7

97.3

2281

14776

R81

ICPC

Pneumonia

2.9

97.2

491

1774

3025

Kela drug reimbursment

Calcium carbonate

8.6

96.9

124

146

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.8

96.9

1842

11258

I49.5

ICD-10 Finland

Sick sinus syndrome

2.7

96.7

543

2074

RS220, ,

NOMESCO Finland

5.3

96.6

195

372

I50

ICD-10 Finland

Heart failure

2.9

96.5

464

1632

K65.0

ICD-10 Finland

Acute peritonitis

5.4

96.2

191

359

GD2SN

NOMESCO Finland

Lung ventilation SPECT

7.7

96.1

134

175

A10AA01, ,

ATC

3.7

96.1

317

886

R03AC12

ATC

salmeterol; inhalant

2.7

96.0

554

2145

3AC01, ,

NOMESCO Finland

6.4

96.0

160

254

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.5

95.8

4473

34090

WX704

NOMESCO Finland

Intubation

2.2

95.7

897

4314

N02BF01

ATC

gabapentin; oral

2.0

95.6

1127

5907

RD210, ,

NOMESCO Finland

4.3

95.4

249

588

A10BA02

ATC

metformin; oral

1.6

95.2

3028

21156

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

3.6

94.9

315

884

ZXD10

NOMESCO Finland

Scheduled procedure

1.6

94.9

3790

27898

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.6

94.5

564

2220

FPH96

NOMESCO Finland

Other removal of cardiac pacemaker or cardioverter-defibrillator

11.1

94.4

100

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

4.2

93.6

250

601

R4120

NOMESCO Finland

Occupational therapy

2.3

93.0

731

3267

C09AA02

ATC

enalapril; systemic

1.7

92.2

2162

13980

N06AX26

ATC

vortioxetine; oral

2.3

92.1

781

3604

M05BA04

ATC

alendronic acid; oral

2.0

92.1

1052

5449

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.9

91.7

1360

7698

SPAT1053

SPAT

Memory test

1.8

91.6

1744

10647

ZST00

NOMESCO Finland

Procedure related to previous procedure classified in chapter T

34.3

91.5

R1250

NOMESCO Finland

Evaluation of functional capability

3.5

91.4

329

974

Z99.2

ICD-10 Finland

Dependence on renal dialysis

45.2

91.3

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.2

91.1

805

3779

D11

ICPC

Diarrhoea

1.9

90.6

1243

6858

SPAT1252

SPAT

Overall medication plan or its review

2.2

90.5

818

3875

R03AK07

ATC

formoterol and budesonide; inhalant

1.7

90.4

2026

12936

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

3.1

90.2

389

1286

TJA33

NOMESCO Finland

Percutaneous introduction of peritoneal dialysis catheter

18.8

90.0

A12AA12

ATC

[U] calcium acetate

18.8

90.0

B01AB10

ATC

tinzaparin; parenteral

2.0

90.0

1152

6208

M54.4

ICD-10 Finland

Lumbago with sciatica

1.7

89.9

1794

11093

S22.3

ICD-10 Finland

Fracture of rib

2.2

89.7

834

3994

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

3.1

89.5

377

1229

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.7

89.4

1924

12145

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

4.9

89.4

196

402

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

2.6

89.1

561

2266

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

6.6

88.9

144

222

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.6

88.8

2722

18794

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

88.5

3958

29736

XCK10

NOMESCO Finland

Photography of fundus of eye

2.0

88.5

1088

5780

SPAT1310

SPAT

Counselling related to known health issue

1.6

88.4

3248

23378

A40.3

ICD-10 Finland

Sepsis due to Streptococcus pneumoniae

185.6

88.4

KBV00

NOMESCO Finland

Insertion of stent into ureter

7.2

88.2

131

184

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.9

88.0

417

1454

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

3.4

88.0

321

958

R96

ICPC

Asthma

2.0

87.9

1086

5778

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.8

87.8

1398

8082

JJ9AE

NOMESCO Finland

Ultrasound examination of liver transplant

21.8

87.8

PB1AC

NOMESCO Finland

Angiography of upper extremity with X-ray

28.2

87.6

C08CA02

ATC

felodipine; oral

1.9

87.5

1161

6330

S29

ICPC

Skin symptom/complaint other

1.7

87.4

2229

14701

E66.01

ICD-10 Finland

Obesity due to excess calories

2.1

87.1

862

4229

H04.10

ICD-10 Finland

Dry eye syndrome

1.9

87.0

1230

6847

D70.82

ICD-10 Finland

Drug-induced neutropenia

4.6

86.9

206

451

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

4.5

86.6

214

484

U14

ICPC

Kidney symptom/complaint

4.0

86.5

247

624

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

2.4

86.5

625

2691

R28

ICPC

Limited function/disability (R)

4.6

85.9

208

463

A02BA02

ATC

ranitidine; systemic

1.7

85.9

2019

13034

R04.0

ICD-10 Finland

Epistaxis

2.1

85.7

920

4654

R10.0

ICD-10 Finland

Acute abdomen

3.0

85.3

397

1371

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

4.9

85.2

187

384

I47.2

ICD-10 Finland

Ventricular tachycardia

3.7

85.1

277

767

I25.2

ICD-10 Finland

Old myocardial infarction

2.1

85.0

821

3989

SPAT1097

SPAT

Recording of ECG

1.8

85.0

1603

9741

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.9

84.9

1256

7092

K07

ICPC

Swollen ankles/oedema

2.4

84.9

624

2707

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.0

84.8

1086

5846

T78.4

ICD-10 Finland

Allergy, unspecified

2.6

84.5

496

1935

R13

ICD-10 Finland

Dysphagia

2.1

84.4

820

3993

GD1UN

NOMESCO Finland

Lung circulation SPECT

8.2

84.4

112

138

G43.9

ICD-10 Finland

Migraine, unspecified

2.5

84.3

570

2380

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.0

84.3

1022

5400

R03AK08

ATC

formoterol and beclometasone; inhalant

2.6

84.2

505

1991

H53.1

ICD-10 Finland

Subjective visual disturbances

2.2

84.0

786

3771

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.0

84.0

948

4882

R05

ICD-10 Finland

Cough

1.6

83.9

2244

14957

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.0

83.1

950

4915

F60.9

ICD-10 Finland

Personality disorder, unspecified

5.4

83.0

164

307

N05AH02

ATC

clozapine; systemic

4.3

82.4

212

495

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

9.0

82.2

101

113

PBM10

NOMESCO Finland

Closure of arteriovenous fistula of radial artery

20.8

82.1

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.9

82.1

1150

6377

K02.1

ICD-10 Finland

Caries of dentine

1.5

81.9

5638

45979

A12BA01

ATC

potassium chloride; oral

2.4

81.7

565

2383

C07AG02

ATC

carvedilol; oral

2.2

81.4

702

3258

J20.5

ICD-10 Finland

Acute bronchitis due to respiratory syncytial virus

7.4

81.1

117

159

G63.2*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic polyneuropathy

10.8

80.8

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.8

80.6

411

1491

N06AB03

ATC

fluoxetine; oral

1.9

80.5

1161

6495

Angiography of the heart and coronary arteries

2.2

80.5

765

3691

R03BA01

ATC

beclometasone; inhalant

1.8

80.4

1412

8394

E66.8

ICD-10 Finland

Other obesity

2.5

80.3

513

2085

FPW96

NOMESCO Finland

Other operation for arhythmia or disturbance of impulse propagation

8.3

80.3

105

127

S01.0

ICD-10 Finland

Open wound of scalp

2.0

80.2

926

4805

G72.8

ICD-10 Finland

Other specified myopathies

4.1

80.2

225

561

G53.0

ICD-10 Finland

Postzoster neuralgia

5.7

80.1

150

267

F29

ICD-10 Finland

Unspecified nonorganic psychosis

3.0

80.0

366

1251

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.7

79.9

449

1714

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

79.8

4376

34066

FPG30

NOMESCO Finland

Implantation of cardioverter-defibrillator with ventricular electrode

9.1

79.8

107

F06.7

ICD-10 Finland

Mild cognitive disorder

2.8

79.7

417

1534

XF606

NOMESCO Finland

Ortostatic test

6.3

79.7

135

218

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.6

79.5

2130

14181

J01CA08

ATC

pivmecillinam; oral

1.5

79.4

3673

27624

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.7

79.2

1939

12619

N05AN01

ATC

lithium; oral

3.6

79.1

265

748

M03BC01

ATC

orphenadrine (citrate); systemic

1.6

79.1

1985

12999

T86.1

ICD-10 Finland

Kidney transplant failure and rejection

40.2

78.8

B00.19

ICD-10 Finland

Other vesicular dermatitis caused by the herper simplex virus

6.5

78.8

128

198

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

3.4

78.7

291

876

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.8

78.6

1438

8646

A10BH01

ATC

sitagliptin; oral

1.9

78.6

1030

5583

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

8.6

78.6

100

117

A08

ICPC

Swelling

2.2

78.3

686

3203

A07AA11

ATC

rifaximin; oral

13.9

78.3

7151

FHL

Kidney transplantation

46.2

78.0

A04AA01

ATC

ondansetron; systemic, rectal

2.0

78.0

865

4423

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

3.5

77.9

268

770

SPAT1245

SPAT

Provision of support and information to patient’s family members

2.4

77.9

566

2441

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

4.5

77.8

191

430

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

4.1

77.8

217

539

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.0

77.7

859

4386

H03AA01

ATC

levothyroxine sodium; systemic

1.6

77.7

2225

15043

C08CA13

ATC

lercanidipine; oral

1.7

77.6

1609

10017

PG1XE

NOMESCO Finland

Other ultrasound examination of blood vessel not elsewhere classified

6.5

77.6

127

198

Z00.0

ICD-10 Finland

General medical examination

1.6

77.5

2052

13611

A10AA02, ,

ATC

2.8

77.5

388

1394

N18.4

ICD-10 Finland

Chronic kidney disease, stage 4

4.7

77.4

180

388

N05AF03

ATC

chlorprothixene; systemic

3.4

77.2

283

847

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

2.6

77.1

456

1785

U04

ICPC

Incontinence urine

2.2

77.1

720

3449

H25.1

ICD-10 Finland

Senile nuclear cataract

1.5

76.8

3212

23622

NF1AA

NOMESCO Finland

Hip X-ray examination

1.9

76.7

1063

5867

C08CA05

ATC

nifedipine; systemic

2.1

76.5

735

3560

GD1BT

NOMESCO Finland

Biopsy of lung with X-ray guidance

24.7

76.5

R00.1

ICD-10 Finland

Bradycardia, unspecified

2.6

76.3

451

1765

J11.8

ICD-10 Finland

Influenza with other manifestations, virus not identified

5.9

76.3

136

231

P03

ICPC

Feeling depressed

2.0

76.2

942

5003

D07AC01

ATC

betamethasone; topical

1.5

75.9

3595

27107

J45

ICD-10 Finland

Asthma

1.9

75.8

1059

5859

M79.0

ICD-10 Finland

Rheumatism, unspecified

3.0

75.8

353

1219

ZY000

NOMESCO Finland

Hospital inpatient

4.9

75.6

166

341

P76

ICPC

Depressive disorder

2.3

75.3

632

2899

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

3.3

75.2

293

911

WZC30

NOMESCO Finland

Teaching

1.7

75.1

1687

10722

C09CA01

ATC

losartan; oral

1.5

75.1

2676

19000

N08.2*D89.80

ICD-10 Finland

Immunoglobulin A (IgA) nephropathy

7.8

75.0

104

135

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

2.0

74.9

924

4903

B97.4

ICD-10 Finland

Respiratory syncytial virus as the cause of diseases classified to other chapters

17.5

74.8

SPAT1231

SPAT

Assessment of adjustments needed in living environment

3.5

74.7

263

767

A10AE06

ATC

insulin degludec; parenteral

2.8

74.7

391

1438

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.9

74.5

977

5292

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

3.5

74.2

262

766

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.8

74.0

372

1339

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.8

74.0

394

1462

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

3.5

74.0

262

767

ZYB02

NOMESCO Finland

Outreach service at unit of another specialty

10.2

74.0

G04CA02

ATC

tamsulosin; oral

1.5

73.8

2673

19033

A08.0

ICD-10 Finland

Rotaviral enteritis

9.3

73.6

F43.1

ICD-10 Finland

Post-traumatic stress disorder

3.3

73.5

276

839

TFJ02

NOMESCO Finland

Muscle biopsy of heart

15.8

73.4

M79.7

ICD-10 Finland

Fibromyalgia

2.9

73.4

361

1284

F10.09

ICD-10 Finland

Alcohol intoxication UNS

3.8

73.3

228

612

WVA20

NOMESCO Finland

Medicine administration

2.9

73.3

351

1231

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

3.8

73.2

230

622

A06

ICPC

Fainting/syncope

4.1

73.1

205

511

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

2.7

72.9

398

1496

R06.4

ICD-10 Finland

Hyperventilation

4.1

72.9

202

499

H05BX02

ATC

paricalcitol; systemic

37.7

72.7

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.8

72.6

379

1392

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

3.0

72.6

323

1087

K08.3

ICD-10 Finland

Retained dental root

2.0

72.3

853

4455

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.6

72.2

442

1759

H04AA01

ATC

glucagon; nasal, parenteral

3.5

72.2

257

755

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

5.3

72.0

145

276

K59.0

ICD-10 Finland

Constipation

2.1

71.8

687

3320

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.7

71.6

396

1499

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

5.0

71.5

154

311

K92.0

ICD-10 Finland

Haematemesis

3.1

71.5

303

991

183

Kela drug reimbursment

Lamotrigin and topiramate

5.9

71.4

129

222

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.3

71.4

554

2458

X57

ICD-10 Finland

Unspecified privation

3.2

71.2

285

901

SPAT1211

SPAT

Application of soft bandage

1.9

71.2

967

5297

S76

ICPC

Skin infection other

2.2

71.1

608

2809

M48.0

ICD-10 Finland

Spinal stenosis

1.7

71.0

1354

8222

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

3.9

70.8

214

563

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.5

70.8

3548

26962

EBA00

NOMESCO Finland

Extraction of tooth

1.5

70.8

3608

27509

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

3.8

70.7

219

586

J13

ICD-10 Finland

Pneumonia due to Streptococcus pneumoniae

6.3

70.6

118

188

D09

ICPC

Nausea

2.4

70.6

531

2324

C07AA05

ATC

propranolol; systemic

1.6

70.6

1821

11972

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

6.0

70.5

124

208

D10

ICPC

Vomiting

2.3

70.2

583

2661

P99

ICPC

Psychological disorders other

3.0

70.0

310

1040

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

2.5

69.9

452

1847

L03

ICPC

Low back symptom/complaint

1.5

69.5

2837

20674

B00.5

ICD-10 Finland

Herpesviral ocular disease

9.5

69.4

N01

ICPC

Headache

1.8

69.4

1129

6542

J15.8

ICD-10 Finland

Other bacterial pneumonia

5.6

69.3

132

239

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.7

69.3

1294

7808

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

69.2

6884

59272

I33.0

ICD-10 Finland

Acute and subacute infective endocarditis

9.9

69.2

R03BB01

ATC

ipratropium bromide; inhalant

2.5

69.1

457

1887

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

2.6

68.9

418

1656

J01FA10

ATC

azithromycin; systemic

1.4

68.9

5264

43194

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.2

68.6

622

2943

R25.1

ICD-10 Finland

Tremor, unspecified

2.7

68.2

384

1466

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

4.7

68.0

160

348

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

2.6

68.0

400

1561

E000001, ,

ATC

1.6

67.9

1902

12741

S80.0

ICD-10 Finland

Contusion of knee

2.0

67.9

774

3990

N03AX18

ATC

lacosamide; systemic

5.7

67.9

127

226

SPAT1153

SPAT

Removal of sutures

1.5

67.9

3144

23481

L84

ICD-10 Finland

Corns and callosities

2.6

67.9

406

1598

A10BB12

ATC

glimepiride; oral

2.0

67.8

772

3979

A01AB09

ATC

miconazole; local oral

1.9

67.7

899

4884

D07AB02

ATC

hydrocortisone butyrate; topical

1.5

67.6

2859

20965

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

5.1

67.5

143

285

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.9

67.4

850

4539

C01AA05

ATC

digoxin; systemic

1.9

67.2

953

5290

PB1DE

NOMESCO Finland

Upper extremity arteries ultrasound examination with Doppler method

9.7

67.1

C90.0

ICD-10 Finland

Multiple myeloma

4.5

67.1

163

364

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.1

67.1

676

3331

FJA10

NOMESCO Finland

Transvenous biopsy of right ventricle

8.6

67.0

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.8

66.9

1016

5763

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

6.7

66.8

105

157

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.7

66.7

1359

8394

Z94.9

ICD-10 Finland

Transplanted organ and tissue status, unspecified

24.8

66.7

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

5.4

66.5

132

248

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

2.4

66.3

459

1935

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.5

66.3

427

1741

K77

ICPC

Heart failure

2.9

66.3

329

1176

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

6.2

66.3

114

187

H3601, E103,

ICD-10 Finland

5.9

66.1

119

204

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

3.6

66.1

218

609

N05BE01

ATC

buspirone; oral

2.9

66.1

314

1096

N05BA12

ATC

alprazolam; oral

1.9

66.1

940

5221

0086X

ICD-9 Finland

Intestinal infections due to other organisms, Enteritis due to specified virus[ENTERITIS VIROSA NUD]

7.2

65.8

138

R03AC03

ATC

terbutaline; inhalant

1.7

65.8

1301

7967

I44.2

ICD-10 Finland

Atrioventricular block, complete

2.7

65.7

358

1344

F20.9

ICD-10 Finland

Schizophrenia, unspecified

3.5

65.7

225

645

N03AX11

ATC

topiramate; oral

3.4

65.6

244

737

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.5

65.6

2554

18389

R06.2

ICD-10 Finland

Wheezing

2.3

65.6

496

2175

I46.9

ICD-10 Finland

Cardiac arrest, unspecified

10.5

65.6

TQW80

NOMESCO Finland

Local dermatologic skincare

2.8

65.6

327

1172

SPAT1104

SPAT

Monitoring of emergency patient

2.0

65.3

706

3570

I20.00

ICD-10 Finland

Unstable angina

2.6

65.2

381

1482

N03.9

ICD-10 Finland

Chronic nephritic syndrome, unspecified

9.5

65.0

M10.3

ICD-10 Finland

Gout due to impairment of renal function

7.7

64.9

117

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.8

64.5

321

1149

C10AC01

ATC

colestyramine; oral

2.8

64.4

325

1172

R04.2

ICD-10 Finland

Haemoptysis

2.5

64.3

419

1718

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

3.5

64.3

221

635

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.4

64.2

5149

42405

IGY99

NOMESCO Finland

Other psychiatric treatment contact

3.4

64.2

239

723

S00.0

ICD-10 Finland

Superficial injury of scalp

2.9

64.1

308

1082

H3603, E107,

ICD-10 Finland

25.1

64.1

WX726

NOMESCO Finland

High-flow oxygen therapy

15.8

64.0

S70.0

ICD-10 Finland

Contusion of hip

2.4

64.0

479

2091

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.5

64.0

417

1710

SPAT1167

SPAT

Insertion of urinary catheter

2.6

63.9

392

1561

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

6.8

63.8

100

149

SPAT1312

SPAT

General health counselling

1.5

63.8

3136

23633

I42.0

ICD-10 Finland

Dilated cardiomyopathy

2.9

63.7

312

1107

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.3

63.7

527

2401

J20

ICD-10 Finland

Acute bronchitis

1.8

63.6

1021

5885

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.8

63.5

965

5469

ZZA00

NOMESCO Finland

Split skin graft

2.8

63.4

332

1221

PH1AC

NOMESCO Finland

Flebography of over extremity with X-ray

3.9

63.4

190

497

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

3.0

63.3

291

997

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

4.9

63.3

138

282

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

3.7

63.3

203

557

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

3.3

63.2

246

765

R4180

NOMESCO Finland

Podiatric therapy

4.3

63.1

163

382

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.8

63.1

974

5548

I20.90

ICD-10 Finland

Angina pectoris, unspecified

2.4

62.9

433

1821

B00.2

ICD-10 Finland

Herpesviral gingivostomatitis and pharyngotonsillitis

7.6

62.7

116

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

2.8

62.6

332

1229

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

3.4

62.6

226

670

177

Kela drug reimbursment

Insulin glargine 300 U / ml

3.5

62.5

219

637

ZXH04

NOMESCO Finland

Procedure performed in other inpatient unit

7.0

62.5

137

Z08

ICPC

Social welfare problem

4.1

62.4

171

419

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.1

62.0

596

2883

J01XX08

ATC

linezolid; systemic

6.7

61.7

148

P01

ICPC

Feeling anxious/nervous/tense

1.8

61.7

1101

6546

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

2.6

61.7

371

1464

N06AX03

ATC

mianserin; oral

2.3

61.6

483

2151

J43.9

ICD-10 Finland

Emphysema, unspecified

3.5

61.5

212

610

-1, ,

NOMESCO Finland

1.5

61.5

3057

23051

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.2

61.4

560

2653

M05BX04

ATC

denosumab; parenteral

2.0

61.4

699

3599

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

3.1

61.3

256

830

R03AC13

ATC

formoterol; inhalant

2.2

61.3

517

2374

R29

ICPC

Respiratory symptom/complaint other

2.0

61.1

706

3654

J01DA09

ATC

[U] cefadroxil

1.5

61.1

2390

17187

UJF92

NOMESCO Finland

Capsular endoscopy

3.2

61.1

248

791

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.3

61.0

468

2065

PB1BC

NOMESCO Finland

Extensive angiography of upper extremity with X-ray

17.3

60.9

WX720

NOMESCO Finland

Own respiration

2.2

60.7

526

2441

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

3.3

60.5

229

700

N05CF02

ATC

zolpidem; oral

1.6

60.4

1544

10092

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

6.1

60.3

104

171

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

9.5

60.3

B27.0

ICD-10 Finland

Gammaherpesviral mononucleosis

5.4

60.3

118

219

SPAT1172

SPAT

Guidance concerning hydration

2.8

60.3

309

1124

B00.10

ICD-10 Finland

Herpes simplex facialis

5.1

60.2

127

252

A08.5

ICD-10 Finland

Other specified intestinal infections

5.5

60.0

116

213

N06DX01

ATC

memantine; oral

1.8

59.9

937

5356

D64.8

ICD-10 Finland

Other specified anaemias

3.1

59.8

254

832

N17

ICD-10 Finland

Acute renal failure

12.7

59.7

GD1LA

NOMESCO Finland

3.7

59.5

191

524

F03

ICD-10 Finland

Unspecified dementia

2.2

59.4

542

2568

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.9

59.2

855

4767

F61.0

ICD-10 Finland

Mixed personality disorders

4.0

59.1

168

423

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

3.9

59.1

173

445

G05.1*B00.4

ICD-10 Finland

Herpesviral meningoencephalitis

22.7

58.9

GD1RA

NOMESCO Finland

Dynamic X-ray examination of respiratory organs with convetional X-ray picture

22.7

58.9

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.8

58.9

977

5681

N04AA02

ATC

biperiden; systemic

3.5

58.9

209

613

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.7

58.9

1118

6759

S01

ICPC

Pain/tenderness of skin

2.2

58.9

528

2485

FPH10

NOMESCO Finland

Open removal of transvenous cardiac pacemaker or cardioverter-defibrillator

15.5

58.8

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.0

58.6

644

3274

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

2.0

58.5

689

3589

C03AA03

ATC

hydrochlorothiazide; oral

1.8

58.5

973

5664

R01AD09

ATC

mometasone; nasal

1.4

58.4

4059

32435

OAB50, ,

SPAT

1.9

58.2

847

4732

SPAT1325

SPAT

Vaccination

1.4

58.2

3488

27160

R05FB02

ATC

cough suppressants and expectorants; systemic

1.4

58.1

3480

27091

G53.0*B02.20

ICD-10 Finland

Trigeminal neuralgia after shingles

9.0

58.0

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.9

57.6

805

4439

I49.0

ICD-10 Finland

Ventricular fibrillation and flutter

4.8

57.5

129

270

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

3.0

57.5

257

867

C01BD01

ATC

amiodarone; systemic

2.6

57.4

334

1296

N04.9

ICD-10 Finland

Nephrotic syndrome, unspecified

9.3

57.4

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

2.9

57.4

271

943

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

4.5

57.4

141

318

G30.1

ICD-10 Finland

Alzheimer disease with late onset

1.9

57.4

782

4278

F10.25

ICD-10 Finland

Alcohol dependence continuous use

3.8

57.3

177

473

F10.20

ICD-10 Finland

Alcohol dependence currently independent

3.5

57.1

203

596

WX212

NOMESCO Finland

Femoral plexus blockade

2.7

57.0

303

1123

R52.1

ICD-10 Finland

Chronic intractable pain

5.0

57.0

123

249

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

4.4

56.9

142

324

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

3.3

56.9

219

676

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

2.4

56.8

386

1613

N04BC05

ATC

pramipexole; oral

1.9

56.7

783

4301

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

3.7

56.7

179

486

M79.1

ICD-10 Finland

Myalgia

1.6

56.5

1386

8955

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

3.7

56.5

182

501

SPAT1251

SPAT

Organisation of medication

2.4

56.4

400

1704

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

3.0

56.2

255

868

H3600, E103,

ICD-10 Finland

4.7

56.0

129

276

J18.1

ICD-10 Finland

Lobar pneumonia, unspecified

4.0

56.0

158

396

N05AB03

ATC

perphenazine; systemic, rectal

2.5

56.0

347

1389

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

5.0

56.0

119

238

M03BX02

ATC

tizanidine; oral

1.4

55.9

5534

46759

E27.1

ICD-10 Finland

Primary adrenocortical insufficiency

10.6

55.9

G04.9

ICD-10 Finland

Encephalitis, myelitis and encephalomyelitis, unspecified

8.9

55.7

U02

ICPC

Urinary frequency/urgency

1.6

55.6

1459

9579

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.8

55.6

286

1042

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

2.9

55.6

274

976

WX213

NOMESCO Finland

Lower leg blockade

4.9

55.6

121

247

TK824

NOMESCO Finland

Replacement of peritoneal dialysis catheter extension tube

16.3

55.5

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

3.4

55.4

201

598

K78

ICPC

Atrial fibrillation/flutter

1.8

55.3

894

5156

A05AA02

ATC

ursodeoxycholic acid; oral

3.5

55.3

190

546

FPE00

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with ventricular electrode

2.9

55.2

272

969

Z50.1

ICD-10 Finland

Other physical therapy

2.1

55.1

543

2650

JAH00

NOMESCO Finland

Laparotomy

2.7

55.0

307

1167

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.3

54.8

409

1783

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.2

54.7

492

2317

K83.0

ICD-10 Finland

Cholangitis

3.7

54.7

176

484

U05

ICPC

Urination problems other

2.0

54.6

602

3062

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.6

54.6

1585

10655

R03AK03

ATC

[U] fenoterol and ipratropium bromide

2.1

54.5

558

2762

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

2.3

54.5

442

1996

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.0

54.4

630

3260

RS222, ,

NOMESCO Finland

4.0

54.2

157

401

R4130

NOMESCO Finland

Speech therapy

2.7

54.2

298

1124

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.0

54.2

636

3307

D07AA02

ATC

hydrocortisone; topical

1.6

54.2

1305

8388

RK320, ,

NOMESCO Finland

4.7

54.2

124

264

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

3.0

54.0

240

807

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.9

54.0

256

893

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

3.6

53.9

178

498

C01CA24

ATC

epinephrine; parenteral

2.1

53.7

551

2729

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.7

53.7

306

1175

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

3.1

53.7

223

721

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.8

53.7

832

4736

N29

ICPC

Neurological sympt/complt other

3.0

53.7

243

826

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

3.4

53.6

193

572

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.6

53.4

1550

10412

Y94.0

ICD-10 Finland

Accident at home

3.0

53.3

240

813

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

3.7

53.3

169

460

U07

ICPC

Urine symptom/complaint other

1.8

53.3

893

5203

K06.18

ICD-10 Finland

Another gingival hyperplasia

8.1

53.3

B01AB04

ATC

dalteparin; parenteral

2.1

53.0

540

2668

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.6

53.0

1211

7680

H36.01

ICD-10 Finland

Diabetic maculopathy

3.8

52.9

161

426

Z00.8

ICD-10 Finland

Other general examinations

1.8

52.8

825

4707

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.7

52.8

1097

6787

6BA02, ,

NOMESCO Finland

9.7

52.7

RJ411, ,

NOMESCO Finland

6.5

52.6

134

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

6.6

52.5

128

WW300

NOMESCO Finland

Transfer of autologic stem cells

9.1

52.4

TPX15

NOMESCO Finland

Removal of vascular injection port

7.4

52.4

104

A49.8

ICD-10 Finland

Other bacterial infections of unspecified site

5.0

52.3

113

229

E83.51

ICD-10 Finland

Hypocalcemia

5.9

52.3

161

L12

ICPC

Hand/finger symptom/complaint

1.5

52.2

1672

11477

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.6

52.2

1447

9614

F99

ICD-10 Finland

Mental disorder, not otherwise specified

3.3

52.2

203

631

I35.0

ICD-10 Finland

Aortic (valve) stenosis

1.9

52.2

703

3828

A11

ICPC

Chest pain NOS

1.8

52.1

908

5349

R35

ICD-10 Finland

Polyuria

1.9

52.0

749

4166

B01.9

ICD-10 Finland

Varicella without complication

6.9

52.0

117

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

2.9

51.9

253

896

WW400

NOMESCO Finland

Plasmaferesis

13.8

51.9

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.7

51.9

282

1058

E66.9

ICD-10 Finland

Obesity, unspecified

2.5

51.8

339

1392

M10.0

ICD-10 Finland

Idiopathic gout

2.3

51.8

392

1719

N06AA10

ATC

nortriptyline; systemic

3.2

51.7

210

670

R00.0

ICD-10 Finland

Tachycardia, unspecified

2.3

51.6

416

1873

XKD00

NOMESCO Finland

Uroflowmetry

1.5

51.6

1675

11531

F34.1

ICD-10 Finland

Dysthymia

2.5

51.3

326

1320

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

51.3

3432

27090

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

2.0

51.2

576

2951

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.0

51.1

596

3091

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

4.2

51.1

138

335

IGY02

NOMESCO Finland

Psychiatric monitoring contact

2.6

51.0

311

1235

I67.3

ICD-10 Finland

Progressive vascular leukoencephalopathy

3.4

51.0

182

536

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

3.3

51.0

194

595

M25.5

ICD-10 Finland

Pain in joint

1.4

51.0

2929

22521

B34.2

ICD-10 Finland

Coronavirus infection, unspecified site

4.8

50.9

116

246

H02AA02

ATC

fludrocortisone; oral

4.7

50.9

117

250

B03BA03

ATC

hydroxocobalamin; parenteral

2.0

50.9

618

3250

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.3

50.8

405

1815

L03.9

ICD-10 Finland

Cellulitis, unspecified

2.9

50.8

241

841

N11.9

ICD-10 Finland

Chronic tubulo-interstitial nephritis, unspecified

8.7

50.8

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.4

50.7

352

1485

TQW99

NOMESCO Finland

Other minor procedure on skin

2.0

50.7

557

2828

NGQ20

NOMESCO Finland

Amputation of lower leg

6.4

50.6

133

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.8

50.4

259

944

A10AD05

ATC

insulin aspart; parenteral

3.0

50.3

221

739

J01CE02

ATC

phenoxymethylpenicillin; oral

1.4

50.2

6337

55195

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.1

50.2

472

2261

H36.00

ICD-10 Finland

Diabetic background retinopathy

3.7

50.2

163

451

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

2.5

50.2

317

1280

QDA10

NOMESCO Finland

Incision of skin of lower limb

5.1

50.2

105

207

N02AC04

ATC

dextropropoxyphene; oral

2.2

50.2

416

1895

WZA90

NOMESCO Finland

Other medical or dental certificate

1.5

50.2

2177

15892

L01BB01, ,

ATC

14.6

50.2

H01

ICPC

Ear pain/earache

1.7

50.1

1129

7127

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

2.8

50.1

257

935

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

4.1

50.0

137

336

C10AA03

ATC

pravastatin; oral

1.8

50.0

778

4432

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.9

50.0

720

4005

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

3.3

49.9

193

598

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

2.1

49.8

470

2256

C09CA06

ATC

candesartan; oral

1.5

49.6

2251

16566

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

2.5

49.6

321

1312

NF3AA

NOMESCO Finland

Femur X-ray examination

2.7

49.6

267

997

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

1.8

49.5

784

4489

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.9

49.5

239

842

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

2.2

49.4

448

2116

FN1AT

NOMESCO Finland

Endovascular dilatation of coronary arteries (PTCA)

2.1

49.4

507

2511

H57.1

ICD-10 Finland

Ocular pain

2.3

49.4

383

1697

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

2.1

49.3

503

2486

I95.8

ICD-10 Finland

Other hypotension

6.4

49.3

127

M13.9

ICD-10 Finland

Arthritis, unspecified

1.8

49.1

716

3998

KMAK, ,

NOMESCO Finland

1.4

49.1

4461

36905

W06

ICD-10 Finland

Fall involving bed

4.2

49.0

129

307

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.1

49.0

499

2464

L03AA02

ATC

filgrastim; parenteral

2.6

49.0

294

1159

R60.1

ICD-10 Finland

Generalized oedema

5.2

48.9

101

197

J04AB02

ATC

rifampicin; systemic

3.9

48.8

142

364

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

3.9

48.8

146

382

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.7

48.7

1014

6269

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

2.8

48.7

246

888

SPAT1279

SPAT

Preparation of immediate hospitalisation

3.8

48.7

151

405

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

4.3

48.7

125

292

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.7

48.6

266

1001

SAA04

NOMESCO Finland

Special examination of mouth

2.0

48.6

519

2608

N28

ICPC

Limited function/disability (N)

3.0

48.6

220

748

N05AD01

ATC

haloperidol; systemic

2.4

48.6

345

1471

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.7

48.5

931

5631

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

3.1

48.5

208

686

H53.2

ICD-10 Finland

Diplopia

2.4

48.4

347

1485

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

2.1

48.4

498

2469

SFA10

NOMESCO Finland

One-surface restoration

1.3

48.4

5092

43039

R03BA08

ATC

ciclesonide; inhalant

1.8

48.3

787

4544

TKC10

NOMESCO Finland

Percutaneous puncture of bladder

3.5

48.3

168

487

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

9.7

48.3

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.3

48.3

376

1669

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.7

48.3

1029

6402

D01

ICPC

Abdominal pain/cramps general

1.6

48.2

1186

7651

A99

ICPC

Disease/condition unspecnature/site

1.7

48.1

1058

6634

L04AX04

ATC

lenalidomide; oral

5.7

48.1

157

153

Kela drug reimbursment

Lenalidomid

5.6

48.1

164

D70.89

ICD-10 Finland

Neutropenic splenomegaly

3.8

48.0

149

400

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.1

48.0

500

2490

N06AX12

ATC

bupropion; oral

2.0

48.0

567

2954

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

6.5

47.9

121

PD5AD

NOMESCO Finland

CT of aorta

2.6

47.9

281

1095

S09.9

ICD-10 Finland

Unspecified injury of head

3.1

47.9

200

649

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

3.0

47.9

219

749

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

4.6

47.8

114

251

G40.19

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

5.2

47.8

190

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3022313) Gas panel - Capillary blood

1259

3982

3.45

322.46

10.0

3.2

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1922

7759

2.80

322.19

3.6

2.3

9.49

6.79

ug/l

2.75

1687

6751

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

755

1657

4.82

320.22

1.5

1.3

3.93

3.72

mmol/l

4.10

712

1564

(3007930) Methemoglobin/Hemoglobin.total in Blood

1195

3679

3.53

319.10

9.1

3.9

0.90

0.87

0.40

1130

3469

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

6281

42330

2.16

319.05

4.5

2.6

—

estimate

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

957

2544

4.03

316.68

1.7

1.2

—

(3044640) Blood type and Crossmatch panel - Blood

4834

29527

2.16

316.42

4.3

2.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

958

1622

6.38

307.65

1.7

1.2

—

(3019069) Monocytes/Leukocytes in Blood

7225

41937

3.19

307.65

12.3

6.1

8.92

8.98

1.07

6962

38906

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

840

1498

6.00

307.65

2.1

1.3

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

2018

5107

4.63

307.65

8.7

3.2

24.02

24.26

mmol/l

2.35

1996

5060

(3002032) Base excess in Venous blood by calculation

3140

8736

4.66

307.65

8.4

3.1

1.82

1.79

mmol/l

0.10

2778

7625

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

3254

16679

2.36

307.65

5.0

2.9

1.09

1.07

e6/l

0.12

1965

8957

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

958

1622

6.38

307.65

1.7

1.2

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

1850

5561

3.81

307.65

6.6

2.7

122.66

130.60

g/l

37.99

1779

5404

(3004789) Transferrin [Mass/volume] in Serum or Plasma

3847

14623

3.54

307.65

4.9

2.2

2.19

2.33

g/l

41.36

3625

13345

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

667

968

7.28

307.65

2.2

1.4

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

5621

28316

3.06

307.65

4.6

2.5

56.70

64.60

u/l

1.99

5327

26053

(3016502) Oxygen saturation in Arterial blood

2968

9047

4.15

307.65

12.5

6.5

94.58

95.76

15.46

2852

8724

(3027801) Oxygen [Partial pressure] in Arterial blood

3319

10121

4.29

307.65

12.1

6.2

10.94

12.59

kpa

70.01

3183

9701

(3003458) Phosphate [Moles/volume] in Serum or Plasma

3919

11082

4.99

307.65

14.4

4.4

1.11

1.02

mmol/l

50.24

3741

10180

(3009261) Glucose [Presence] in Urine by Test strip

7103

49276

2.29

307.65

7.1

3.9

0.63

0.46

estimate

0.10

1612

9783

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1353

2758

5.47

307.65

5.3

2.3

24.81

24.73

mmol/l

0.27

1328

2708

(3047181) Lactate [Moles/volume] in Blood

973

2486

4.20

307.65

9.7

4.4

1.42

1.29

mmol/l

2.44

861

2181

(3021960) Folate [Moles/volume] in Serum or Plasma

4978

27250

2.54

307.65

2.2

1.7

19.49

20.20

nmol/l

2.49

4483

22828

(3031040) Bacteria [#/volume] in Urine by Automated count

8728

60400

3.34

307.65

9.1

4.5

1662.11

2118.76

e6/l

0.28

195

808

(3001604) Monocytes [#/volume] in Blood

7662

45614

3.35

307.65

11.5

5.8

0.63

0.60

e9/l

17.28

6890

38504

(3018677) aPTT in Platelet poor plasma by Coagulation assay

3603

13703

3.45

307.65

3.8

1.8

30.05

29.65

2.96

3515

13338

(3035350) Ketones [Presence] in Urine by Test strip

7073

48956

2.29

307.65

7.1

3.8

7.04

2.89

estimate

1.05

1732

10367

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

3023

10628

3.56

307.65

5.7

4.1

249.95

243.24

u/l

1.44

2884

10032

(1616796) Gas panel - Central venous blood

901

1767

5.47

307.65

6.9

2.8

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1612

4311

4.22

307.65

1.8

1.4

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1049

2552

4.45

307.65

7.9

3.3

2.03

1.43

mg/l

57.80

994

2267

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1567

3065

5.81

307.65

2.7

1.6

3.84

1.25

ug/l

1.77

1396

2666

(3018418) pH of Serum or Plasma

5466

27846

2.95

307.65

9.9

3.5

7.40

1.00

4405

19584

(3027273) Bicarbonate [Moles/volume] in Venous blood

1432

4034

3.94

307.65

6.6

2.7

25.14

25.26

mmol/l

0.51

1370

3917

(3002030) Lymphocytes/Leukocytes in Blood

7251

42940

3.10

307.65

12.3

6.0

24.72

27.77

94.77

7041

40343

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1266

1876

7.51

307.65

2.2

1.4

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

981

2312

4.57

307.65

5.2

2.2

3.62

3.51

g/l

1.16

944

2205

(3013650) Neutrophils [#/volume] in Blood by Automated count

8076

51323

3.29

307.65

17.2

8.7

4.56

4.14

e9/l

39.08

7355

43862

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1973

7370

3.05

307.65

5.4

2.7

265.10

196.34

ng/l

7.92

1838

6710

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

875

1419

6.62

307.65

1.9

1.3

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

8048

47301

3.77

307.65

11.4

5.8

11.17

12.06

umol/l

7.75

7805

44841

(3020779) Urea [Moles/volume] in Serum or Plasma

3210

7225

5.90

307.65

17.2

5.0

12.25

9.14

mmol/l

78.68

3105

6823

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

3644

13406

3.60

307.65

5.0

2.3

20.84

22.46

11.08

3443

12299

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

5031

24979

2.90

307.65

3.3

2.3

3.07

2.82

mg/l

8.82

4543

21379

(3023368) Bacteria identified in Blood by Culture

6713

23996

5.77

307.65

8.0

3.4

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1720

5143

3.79

307.65

14.1

8.0

24.31

mmol/l

0.01

1664

5009

(3021601) Nitrite [Presence] in Urine by Test strip

7014

48406

2.29

307.65

7.1

3.8

0.00

estimate

0.51

1693

10094

(3013115) Eosinophils [#/volume] in Blood

7794

47128

3.36

307.65

12.3

6.0

0.18

0.20

e9/l

6.51

7066

40505

(3010375) cycloSPORINE [Mass/volume] in Blood

441

214

21.44

307.65

35.9

27.8

111.71

115.50

ug/l

0.35

353

185

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

875

1279

7.36

307.65

2.3

1.5

—

(3000991) Gas panel - Venous blood

2583

7618

4.14

307.65

15.7

7.1

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1826

5416

3.86

307.65

11.2

5.5

24.64

24.53

mmol/l

0.47

1750

5176

(3018010) Neutrophils/Leukocytes in Blood

7165

41998

3.11

307.65

11.8

5.9

60.16

57.24

72.67

6972

39873

(3014007) Fractional oxyhemoglobin in Arterial blood

1649

5934

3.10

307.65

16.1

7.9

92.95

94.07

9.06

1643

5918

(3033658) Prothrombin time (PT) actual/Normal

4118

22781

2.31

307.65

8.9

3.7

86.23

87.66

2.78

4029

22298

(3003396) Base excess in Arterial blood by calculation

3297

10035

4.29

307.65

12.0

6.2

1.29

0.88

mmol/l

5.28

2772

8178

(3015736) pH of Urine

5985

38975

2.20

307.65

5.9

3.4

6.32

6.24

6.05

3362

21288

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1104

2998

3.99

307.65

3.4

2.6

—

(44790049) Parainfluenza type 3 nucleic acid detection

682

943

7.65

307.65

2.1

1.3

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

2105

5690

4.35

307.65

8.6

3.1

5.20

5.11

kpa

4.13

2051

5378

(40768446) Kidney Pathology biopsy report

312

209

15.34

307.65

2.2

1.5

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

2210

8253

3.11

307.65

3.2

2.1

0.20

0.21

g/l

3.67

2034

7701

(3019198) Lymphocytes [#/volume] in Blood

7722

46738

3.30

307.65

11.7

5.9

1.84

1.94

e9/l

2.02

7042

40519

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

9299

69389

3.48

307.65

17.0

7.4

83.57

79.39

u/l

11.73

9082

65438

(3000850) Epithelial cells [#/volume] in Urine

4312

21109

2.74

307.65

5.1

2.6

5.43

5.21

e6/l

0.49

4054

19089

(3006315) Basophils [#/volume] in Blood

7674

45768

3.35

307.65

11.6

5.8

0.04

e9/l

5.86

6901

38662

(3012544) pH of Venous blood

3217

9114

4.61

307.65

8.4

3.1

7.37

7.38

11.40

2146

5140

(44790048) Parainfluenza type 2 nucleic acid detection

682

943

7.65

307.65

2.1

1.3

—

(3028626) Oxygen [Partial pressure] in Capillary blood

1112

2257

5.38

307.65

7.7

3.3

8.21

8.43

kpa

3.48

1100

2192

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

6476

42042

2.35

307.65

2.8

2.1

93.37

95.24

pmol/l

2.61

3892

22146

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

2299

9959

2.66

307.65

4.9

2.5

8.77

8.43

umol/l

0.28

2010

8677

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

607

796

8.02

307.65

8.2

5.4

12.29

11.65

mg/l

1.96

563

731

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

732

1132

6.86

307.65

1.9

1.3

—

(3026250) Tacrolimus [Mass/volume] in Blood

472

199

24.76

307.65

51.3

37.3

7.26

7.15

ug/l

0.25

436

174

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

6154

35220

2.74

307.65

7.7

3.6

109.48

66.35

ng/l

0.70

4917

25348

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

2106

6718

3.65

307.65

7.7

3.2

122.54

83.12

ng/l

37.91

1886

5705

(3022096) Basophils/Leukocytes in Blood

7170

41855

3.13

307.65

12.3

6.1

0.60

0.68

30.61

6910

38820

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1513

4781

3.52

307.65

6.2

2.4

1.25

1.18

1.98

1506

4756

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

3896

17701

2.88

307.65

7.3

3.7

526.06

480.82

ng/l

0.07

3274

14233

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

4003

10028

5.76

307.65

2.9

1.7

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1632

4970

3.69

307.65

16.1

8.0

15.59

16.19

13.07

1576

4775

(3037467) Urinalysis macro (dipstick) panel - Urine

8607

62589

2.86

307.65

8.9

4.4

2.06

2.26

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

5629

29174

2.95

307.65

5.5

3.0

2627.97

1371.19

ng/l

30.56

5114

25042

(3002582) Erythrocytes [#/volume] in Urine

5611

30774

2.72

307.65

6.7

3.2

59.92

98.72

e6/l

1.81

4702

23298

(3009343) pH of Capillary blood

2048

5528

4.34

307.65

8.5

3.1

7.41

7.42

7.03

1840

4444

(36304419) Bacteria [Presence] in Urine

4654

25257

2.48

307.65

6.2

3.1

23.07

98.91

estimate

0.35

132

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

795

1592

5.31

307.65

1.7

1.2

31.73

42.54

u/ml

—

(3024928) Oxygen saturation in Venous blood

866

2060

4.48

307.65

6.2

2.6

64.13

60.76

3.65

828

2008

(3023183) Ammonium ion [Moles/volume] in Plasma

944

1360

7.51

307.65

4.0

2.0

31.96

32.45

umol/l

0.18

861

1203

(3036481) Cortisol [Moles/volume] in Serum or Plasma

2288

7779

3.46

307.65

2.5

2.3

355.39

384.78

nmol/l

8.31

2137

7179

(3006184) Hemoglobin [Mass/volume] in Capillary blood

880

2085

4.51

307.65

3.6

1.9

126.47

130.02

g/l

3.42

730

1592

(3006504) Eosinophils/Leukocytes in Blood

7197

41831

3.17

307.65

12.1

6.0

2.60

2.88

22.00

6940

38805

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

709

957

7.86

307.65

2.1

1.4

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1564

3971

4.44

307.65

2.2

1.6

1.58

1.49

g/l

3.00

1392

3359

(3024354) Oxygen [Partial pressure] in Venous blood

2577

7743

4.06

307.65

7.0

2.7

4.83

4.45

kpa

10.38

2503

7551

(3030467) Casts [#/volume] in Urine by Automated count

4923

26674

2.56

307.65

6.3

3.1

0.51

0.40

e6/l

1.77

4014

19470

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

3065

15191

2.42

307.65

5.3

3.0

3.05

2.45

e6/l

2.13

1765

7445

(3020630) Protein [Mass/volume] in Serum or Plasma

2144

7737

3.21

307.65

3.7

2.4

64.25

66.56

g/l

29.64

2002

6987

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1654

5910

3.12

307.65

15.9

7.8

1.37

1.30

1.51

1641

5880

(3028026) IgM [Mass/volume] in Serum or Plasma

1600

4835

3.71

307.65

2.6

1.9

1.28

1.37

g/l

0.65

1494

4417

(3014111) Lactate [Moles/volume] in Serum or Plasma

2587

7869

4.01

307.65

12.4

6.2

1.44

1.32

mmol/l

4.96

2537

7692

(3042936) Bacteria identified in Isolate by Culture

3168

11981

3.33

307.65

3.0

1.8

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

5417

31845

2.41

307.65

4.9

3.3

2.33

2.36

mmol/l

38.16

5011

28703

(3027945) Reticulocytes/Erythrocytes in Blood

2999

10961

3.41

307.65

4.0

2.3

1.93

1.72

18.29

2741

9612

(3019309) Folate [Moles/volume] in Red Blood Cells

3641

16451

2.83

307.65

2.0

1.7

1223.75

1154.46

nmol/l

3.81

2927

12240

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

8136

47051

3.97

307.65

19.4

5.9

1.20

1.22

mmol/l

53.77

7400

40111

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1242

3488

3.89

307.65

1.7

1.5

11.45

18.85

iu/ml

0.97

(3032080) INR in Blood by Coagulation assay

7655

43391

3.64

307.65

25.8

15.4

1.33

1.29

inr

6.49

6844

36077

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

6147

33651

2.92

307.65

6.9

3.2

—

1.70

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

456

592

8.00

307.65

2.1

1.4

—

(44806118) Parainfluenza type 4 nucleic acid detection

681

943

7.64

307.65

2.1

1.3

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

5058

28652

2.44

307.65

5.5

3.0

38.83

33.27

u/l

1.32

4792

26877

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

5339

14430

6.35

307.65

3.0

1.7

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

7378

41432

3.47

307.65

10.7

4.4

33.78

35.73

g/l

140.68

7039

38463

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

772

1482

5.53

307.65

1.7

1.2

284.59

259.37

u/ml

1.33

549

896

(3022948) Iron [Moles/volume] in Serum or Plasma

3998

15724

3.45

307.65

4.9

2.3

11.23

13.07

umol/l

52.97

3778

14470

(3021447) Carbon dioxide [Partial pressure] in Venous blood

3216

8986

4.68

307.65

8.3

3.1

5.89

5.80

kpa

4.73

3127

8778

(3002173) Hemoglobin [Mass/volume] in Arterial blood

2686

8442

3.91

307.65

13.5

6.8

119.34

122.15

g/l

8.54

2622

8233

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

827

1879

4.68

307.65

1.6

1.3

538.96

537.82

mg/l

0.01

789

1790

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1280

2554

5.55

307.65

5.7

2.5

0.31

0.37

iu/ml

7.02

765

1360

(3026782) Osmolality of Urine

3785

18015

2.70

307.65

5.2

2.8

498.03

542.86

mosm/kgh2o

35.30

3469

15663

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1418

4621

3.38

307.65

7.3

3.3

49.91

46.48

5.22

1396

4561

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

3320

10126

4.29

307.65

12.1

6.2

5.12

5.07

kpa

1.70

3184

9717

(3001122) Ferritin [Mass/volume] in Serum or Plasma

6644

41993

2.52

307.65

5.5

2.9

176.32

126.45

ug/l

23.34

6283

38787

(3017143) Hepatitis C virus Ab [Presence] in Serum

2177

9026

2.77

307.65

2.5

1.5

—

(3026493) Urate [Moles/volume] in Serum or Plasma

4190

23694

2.26

307.65

5.2

2.6

370.61

345.22

umol/l

35.64

3757

20631

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

829

1495

5.92

307.65

2.1

1.3

18.74

21.16

u/ml

0.23

(3042733) HLA Ab [Presence] in Serum

331

144

23.68

307.65

5.3

4.5

—

(44790047) Parainfluenza type 1 nucleic acid detection

682

943

7.65

307.65

2.1

1.3

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

5802

28013

3.32

307.65

3.6

2.1

227.98

203.99

u/l

0.79

5600

26329

(46235355) HIV 1 and 2 tests - Meaningful Use set

2947

14447

2.43

307.65

2.5

1.9

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

965

1105

9.49

307.65

5.2

2.4

3819.16

1414.88

u/ml

0.44

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

4266

10687

5.95

307.65

2.8

1.7

—

(3005719) IgG [Mass/volume] in Serum or Plasma

2018

6213

3.77

307.65

4.1

2.7

9.75

10.59

g/l

11.66

1919

5699

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

8682

66487

2.57

307.65

7.6

4.2

17.13

12.02

mm/h

122.56

8317

61704

(3023520) Reticulocytes [#/volume] in Blood

2418

8512

3.37

307.65

3.8

2.3

72.21

67.69

e9/l

5.89

1835

6213

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

6310

40816

2.32

307.65

3.7

2.3

76.02

78.02

nmol/l

6.28

5853

36492

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

520

765

7.09

307.65

2.2

1.5

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1192

1435

9.22

307.65

11.8

4.3

3645.06

1941.77

iu/ml

0.30

305

162

(40767503) Oxygen content in Capillary blood by calculation

786

1665

5.01

307.65

4.8

2.0

15.87

16.63

8.05

774

1633

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

7497

41858

3.60

307.65

17.3

5.4

1.20

1.21

mmol/l

44.15

7206

38284

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1025

1708

6.53

307.65

2.0

1.3

—

(3018095) Leukocytes [#/volume] in Urine

5885

34927

2.51

307.65

8.1

3.8

123.42

98.82

e6/l

0.71

4781

24381

(3019977) pH of Arterial blood

3323

10102

4.31

307.65

12.2

6.2

7.42

0.97

2057

5345

(3013826) Glucose [Moles/volume] in Serum or Plasma

8516

54283

3.71

307.65

13.2

4.3

7.01

6.70

mmol/l

25.91

8310

51221

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1278

1962

7.26

307.65

2.2

1.4

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

4194

14290

4.17

307.65

7.0

2.9

0.81

0.82

mmol/l

7.37

4016

13329

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2528

5855

5.33

307.65

2.4

1.5

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

4183

18705

3.02

307.65

3.0

1.6

1.46

1.24

mg/l

3.02

3468

14365

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

777

1367

6.05

307.65

2.2

1.3

142.52

150.17

au/ml

0.75

226

397

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1887

5249

4.15

307.65

2.4

1.6

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1857

5906

3.59

307.65

14.4

6.9

24.90

24.79

mmol/l

0.49

1842

5865

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1367

2380

6.43

307.65

1.6

1.2

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1628

5685

3.20

307.65

16.1

8.1

0.64

0.06

1615

5657

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1247

2843

4.83

307.65

3.2

2.0

572.97

374.45

ug/l

2.15

1194

2693

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1912

4808

4.62

307.65

8.1

3.0

2.05

1.67

mmol/l

3.27

1468

3452

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

843

1435

6.29

307.65

1.9

1.3

—

(3021901) Oxygen saturation in Capillary blood

913

1649

5.96

307.65

5.2

2.3

90.01

89.91

0.16

900

1597

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1295

4030

3.52

307.65

8.7

3.8

1.70

1.56

5.10

1230

3811

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

473

695

7.07

306.54

2.2

1.5

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

7094

50606

2.18

304.60

4.0

2.8

—

(3024471) HLA-A [Type]

250

148

17.27

303.09

1.0

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

825

2041

4.29

300.46

1.4

1.1

—

(3024932) HLA-DR beta [Type]

246

147

17.10

296.84

1.0

1.1

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1028

3013

3.67

295.00

1.4

1.3

—

(3017181) Myelocytes/Leukocytes in Blood

1904

7996

2.68

293.27

6.4

4.1

0.94

0.89

0.37

995

2093

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

475

741

6.66

290.84

2.4

2.5

26.69

25.77

iu/ml

0.05

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

955

2693

3.79

289.95

4.6

2.9

4.32

3.59

ratio

0.32

588

1549

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

722

1656

4.60

289.57

1.6

1.4

26.13

20.82

e6/l

0.26

557

1234

(3028271) Lactate [Moles/volume] in Capillary blood

602

1185

5.32

289.41

3.0

1.5

1.59

1.71

mmol/l

2.11

593

1154

(3037522) Nuclear Ab [Titer] in Serum

2422

11473

2.43

289.04

1.6

1.3

507.64

522.97

titre

0.15

518

2401

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

726

1676

4.57

288.80

1.6

1.4

1105.92

1302.39

e6/l

0.12

595

1333

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

877

2337

4.00

288.55

2.3

1.6

0.24

0.23

g/l

1.52

823

2220

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1025

3045

3.61

288.03

4.9

3.0

51.84

39.17

mg/l

1.97

847

2601

(3034860) Kappa light chains.free [Mass/volume] in Serum

1024

3049

3.61

286.71

4.9

3.0

62.60

51.53

mg/l

1.92

852

2605

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

889

2423

3.91

283.25

2.3

1.6

1.17

1.19

g/l

0.98

843

2310

(3002179) Metamyelocytes/Leukocytes in Blood

1818

7606

2.67

281.23

6.0

4.0

0.69

0.62

0.95

932

1993

(3007164) IgA [Mass/volume] in Serum or Plasma

3190

17207

2.21

279.02

2.1

1.5

2.50

2.39

g/l

1.55

2156

10149

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

879

2417

3.87

276.40

5.5

2.1

91.07

93.16

1.57

859

2327

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2497

12212

2.36

275.73

2.4

1.6

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

191

25.91

275.50

5.8

7.0

10606.93

5821.88

iu/ml

—

(3023419) Bacteria identified in Sputum by Culture

549

1041

5.50

274.96

3.1

2.5

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

837

2238

3.97

273.75

2.2

1.5

—

(3027315) Oxygen [Partial pressure] in Blood

706

1665

4.47

273.09

8.0

2.7

8.54

8.69

kpa

1.19

690

1624

(3036489) Thrombin time

995

3013

3.54

271.05

4.1

1.9

21.79

21.00

2.50

925

2668

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1916

8374

2.57

270.20

4.0

2.4

40.03

38.97

u/l

0.08

1653

7068

(3012501) Base excess in Blood by calculation

700

1657

4.45

269.43

8.0

2.7

2.78

2.43

mmol/l

1.98

514

1060

(3013290) Carbon dioxide [Partial pressure] in Blood

700

1658

4.45

269.22

8.0

2.7

5.07

4.95

kpa

3.14

684

1617

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

866

2434

3.78

263.54

1.6

1.2

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1048

3341

3.37

263.08

3.1

1.8

—

(3037756) Immunofixation for Serum or Plasma

719

1778

4.26

261.30

1.8

1.5

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

441

715

6.39

259.85

1.4

—

(40758558) Short blood count panel - Blood

4369

27191

2.02

256.69

12.1

5.8

—

(3000494) Fungus identified in Specimen by Culture

2196

10462

2.38

255.28

2.2

1.4

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

3785

22407

2.06

255.22

4.0

2.2

—

(3020891) Body temperature

1204

4282

3.04

251.06

8.3

3.7

36.95

36.90

°c

5.85

1184

4242

(40760888) Immunoglobulin light chains.free panel - Serum

747

1961

4.02

250.18

5.0

3.1

—

0.86

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

806

2240

3.81

249.00

4.4

2.3

211.89

188.39

8.87

780

2134

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

753

2002

3.97

247.72

1.6

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

389

584

6.87

246.74

2.0

1.4

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

562

1199

4.89

245.66

1.2

1.1

1.75

1.01

0.46

(3010421) pH of Blood

901

2729

3.51

244.64

8.0

2.5

7.41

2.42

888

2689

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

358

496

7.43

244.34

1.5

1.2

79.42

81.71

0.19

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

966

3067

3.36

243.50

2.7

1.6

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

7504

57038

2.04

240.74

6.0

3.0

64.16

46.31

u/l

32.66

7171

52954

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

259

245

10.81

238.44

2.8

1.5

32200.33

31071.58

u/ml

0.01

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

803

2308

3.68

235.85

1.8

1.4

14.69

12.54

iu/ml

0.16

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

982

3211

3.26

235.72

10.8

3.4

24.69

24.77

mmol/l

0.34

929

2916

(3021589) Normoblasts [#/volume] in Blood

5774

40358

1.93

234.24

24.6

10.7

0.01

0.00

e9/l

0.99

4830

32681

(3021440) Promyelocytes/Leukocytes in Blood

1734

7717

2.49

232.53

6.6

4.2

0.09

0.11

0.85

833

1830

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

383

611

6.46

229.11

2.1

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

383

611

6.46

229.11

2.1

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

383

611

6.46

229.11

2.1

1.5

—

(3009508) Creatinine [Moles/volume] in Urine

4909

32686

1.92

229.03

5.2

3.3

6.74

7.60

mmol/l

38.70

4317

27370

(3011412) CD3 cells [#/volume] in Blood

411

710

5.98

226.94

2.5

2.3

1163.71

1194.55

e6/l

0.24

356

629

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1470

6113

2.63

226.89

1.8

1.4

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1716

7686

2.47

226.49

4.2

2.3

0.42

0.40

e6/l

0.15

1666

7367

(3018405) Lactate [Moles/volume] in Arterial blood

899

2862

3.34

225.12

6.0

3.5

1.50

1.33

mmol/l

3.05

876

2824

(3025941) Bacteria identified in Stool by Culture

1183

4421

2.88

224.52

1.5

1.2

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

356

543

6.75

222.33

1.3

1.1

—

(3039000) Anion gap in Blood by calculation

656

1707

4.03

221.93

11.6

5.1

11.64

11.17

mmol/l

2.40

595

1517

(3018572) Chloride [Moles/volume] in Blood

656

1708

4.02

221.74

11.6

5.1

104.18

105.14

mmol/l

4.54

595

1519

(3025159) Blasts/Leukocytes in Blood

1706

7786

2.42

215.22

6.8

4.3

0.08

0.23

1.49

774

1733

(3004809) Band form neutrophils/Leukocytes in Blood

550

1292

4.43

213.07

4.4

3.3

1.54

1.40

0.36

511

1131

(3022806) Fractional oxyhemoglobin in Capillary blood

447

888

5.21

212.02

2.8

1.5

89.57

89.90

0.47

441

878

(40760892) CBC W Ordered Manual Differential panel - Blood

3276

19464

1.98

210.28

8.4

4.4

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

346

547

6.50

208.71

2.4

2.1

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1894

9160

2.30

208.56

5.8

3.1

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1046

3800

2.94

208.47

3.2

2.1

3.64

3.70

g/l

0.43

958

3436

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

10059

87860

3.17

207.73

48.5

14.3

25.75

24.74

mg/l

3.04

9581

72123

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1047

3813

2.93

207.71

3.2

2.1

7.50

7.39

g/l

1.16

960

3444

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1046

3808

2.93

207.64

3.2

2.1

4.06

4.21

g/l

6.53

959

3444

(3020682) Albumin/Creatinine [Ratio] in Urine

4671

31301

1.87

207.18

6.0

4.0

22.61

6.93

mg/mmol

29.52

3403

19343

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

3303

19845

1.96

204.05

1.9

1.7

23011833.24

31709403.98

pmol/l

0.44

2816

16191

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

992

3564

2.96

201.47

3.2

2.1

3.02

2.88

g/l

4.03

905

3195

(3003181) Sodium [Moles/volume] in Urine

613

1639

3.91

199.33

1.7

1.3

62.24

63.03

mmol/l

0.16

489

1308

(3019230) Fractional oxyhemoglobin in Venous blood

650

1817

3.74

198.25

6.8

2.3

63.51

61.32

1.50

643

1812

(3012516) Albumin [Mass/volume] in Urine

4567

30691

1.85

198.09

5.1

3.4

104.46

41.88

mg/l

26.30

3418

19498

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

236

254

9.48

197.91

1.1

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

8383

68168

2.03

197.78

5.5

4.2

14.96

14.88

pmol/l

1.77

7860

61915

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

658

1868

3.69

196.14

2.0

1.5

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

138

24.51

195.19

12.5

10.4

4.90

5.20

mmol/l

0.41

138

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

920

3282

2.97

188.85

3.2

2.1

9.65

10.06

g/l

1.62

823

2872

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

3139

18943

1.93

188.61

3.4

3.0

2.46

2.45

mmol/l

2.31

2816

16908

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

222

235

9.62

188.47

3.3

2.4

0.60

0.62

mmol/l

3.26

222

235

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

5176

36546

1.80

187.30

7.2

3.8

0.46

0.25

estimate

0.24

1439

8295

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

587

1593

3.84

186.71

1.8

1.5

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

278

401

7.09

182.76

1.4

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

440

977

4.65

182.70

1.3

1.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

454

1049

4.47

179.33

5.6

4.9

354.03

360.76

umol/l

0.40

406

902

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

116

31.68

179.02

4.8

4.6

2.09

2.32

mg/l

0.22

105

(3014051) Protein [Presence] in Urine by Test strip

3891

25479

1.82

178.69

4.9

2.9

0.28

0.05

1.70

767

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

520

1340

4.03

177.77

1.8

1.4

12.25

12.33

u/ml

0.01

(1175426) CD3 cells/Lymphocytes in Blood

330

585

5.79

177.13

2.3

2.1

73.43

71.25

1.17

312

563

(3011397) Hemoglobin [Presence] in Urine by Test strip

3566

22787

1.84

176.96

6.3

3.7

0.55

0.30

0.43

293

(3020876) Protein [Mass/time] in 24 hour Urine

448

1037

4.46

176.53

2.8

2.2

1.54

1.12

g/24h

1.85

292

570

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

296

479

6.33

174.38

2.0

1.3

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

320

564

5.82

172.79

2.2

2.0

13.31

15.23

1.94

307

551

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

292

480

6.22

169.34

1.7

1.2

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

273

420

6.64

168.93

2.0

1.4

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

10074

89694

2.88

168.84

55.7

17.5

139.10

139.67

mmol/l

82.75

10010

87745

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

293

485

6.18

168.74

2.4

590.63

505.69

e6/l

1.12

227

394

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

547

1515

3.75

168.71

1.4

1.2

88.33

185.93

titre

0.44

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

288

469

6.28

168.59

1.7

1.2

—

(3040151) Glucose [Moles/volume] in Capillary blood

422

966

4.51

168.59

21.9

6.0

7.17

7.34

mmol/l

0.45

391

793

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

885

3283

2.85

168.55

3.4

2.2

1.04

0.77

g/l

0.97

760

2780

(3037692) Legionella sp identified in Specimen by Organism specific culture

213

248

8.74

168.05

1.8

1.4

—

(3029937) Albumin [Presence] in Urine by Test strip

4059

27293

1.78

167.88

7.5

4.0

0.05

0.00

estimate

0.53

1528

9211

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

277

436

6.49

167.66

2.0

1.4

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

544

1510

3.74

167.23

1.4

1.2

227.60

355.94

titre

0.83

112

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

190

193

10.00

166.21

1.1

—

(21494815) CD4 cells/Lymphocytes in Specimen

338

651

5.33

165.76

2.2

2.3

39.02

38.08

0.41

330

640

(3014148) Varicella zoster virus Ab [Titer] in Serum

417

960

4.48

165.37

1.2

1.1

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

10074

89857

2.85

165.08

56.4

17.6

4.02

3.98

mmol/l

32.22

10010

87733

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

259

390

6.78

163.55

4.2

2.1

93.47

98.18

0.96

253

363

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

734

2505

3.07

162.29

1.7

1.3

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

289

492

6.01

161.74

2.5

191.82

239.07

e6/l

2.48

240

419

(3029634) Reagin Ab [Titer] in Serum by VDRL

443

1090

4.20

161.09

2.5

2.0

4.33

10.03

titre

0.56

(3017732) Neutrophils [#/volume] in Blood

2038

11112

2.03

160.87

4.2

3.1

4.83

4.57

e9/l

1.06

1750

9510

(3043409) Potassium [Moles/volume] in Arterial blood

710

2426

3.06

156.54

6.9

3.7

3.93

3.88

mmol/l

1.96

701

2411

(3019150) Specific gravity of Urine by Refractometry

3339

21743

1.78

150.32

6.9

4.0

1.02

1.23

kg/l

1.07

2524

14280

(3044889) 12 lead EKG panel

7641

62448

1.77

149.10

6.5

4.1

0.45

2923.10

0.73

148

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

889

3516

2.67

149.07

2.4

1.8

37.96

39.74

u/l

1.53

796

3102

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

756

2753

2.88

148.53

3.2

2.1

0.02

g/l

0.07

688

2452

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

9354

81596

2.11

147.58

7.0

5.2

1.98

1.96

mu/l

0.21

8856

74813

(3000570) Elastase.pancreatic [Mass/mass] in Stool

729

2617

2.92

147.00

1.5

1.4

266.78

274.28

ug/g

0.43

448

1555

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

139

107

13.15

145.87

1.9

1.2

14165.38

5364.44

u/ml

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

251

412

6.21

145.72

1.2

1.1

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

255

432

6.02

143.38

1.1

1.0

289.07

354.04

ng/l

1.55

203

271

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

727

2652

2.87

142.23

3.2

2.2

0.00

g/l

0.76

646

2299

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

254

433

5.98

141.91

1.1

1.0

775.98

700.80

ng/l

1.36

193

266

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

254

435

5.96

141.23

1.1

1.0

34.16

46.75

ng/l

4.75

195

272

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

232

363

6.51

141.19

1.2

1.1

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

293

577

5.19

140.06

1.4

1.2

2.24

1.99

mmol/l

1.44

273

535

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

340

760

4.59

139.79

1.1

44.36

67.11

au/ml

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

207

292

7.21

138.79

2.9

2.7

154.78

122.69

umol/l

0.53

114

153

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

224

344

6.63

138.79

2.4

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

224

344

6.63

138.79

2.4

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

224

344

6.63

138.79

2.4

1.6

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

224

344

6.63

138.79

2.4

1.6

—

(3041096) Erythrocytes [Presence] in Urine by Automated

3729

25492

1.71

138.63

6.3

3.3

0.39

0.31

estimate

0.11

1390

7955

(3005322) IgE [Units/volume] in Serum or Plasma

1153

5322

2.31

137.96

1.5

1.3

244.01

255.03

u/ml

0.11

1066

4945

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1709

9228

2.01

136.49

2.2

1.7

1.64

1.46

15.37

1489

8063

(3017569) Oxygen content in Arterial blood

243

413

6.00

136.17

2.4

2.0

15.84

15.93

0.15

243

413

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

3073

20031

1.75

134.97

1.4

1.3

2.00

1.87

u/ml

0.16

779

5215

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

682

2472

2.88

134.87

3.3

2.2

0.00

g/l

-0.00

643

2295

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

338

774

4.48

134.80

1.2

1.1

—

(3023420) DNA double strand Ab [Units/volume] in Serum

831

3347

2.61

133.89

2.4

1.7

10.45

7.19

iu/ml

1.48

213

805

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

240

410

5.96

133.78

2.7

2.6

38.96

39.03

0.01

136

227

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

341

799

4.37

132.05

1.1

30.92

11.44

au/ml

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

330

754

4.48

131.97

5.0

3.5

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

471

1392

3.49

131.42

1.6

1.7

0.61

0.82

g/l

4.52

356

1100

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

321

725

4.53

130.25

3.7

2.3

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

488

1484

3.40

130.21

1.9

1.5

—

(3023410) Appearance of Cerebral spinal fluid

319

720

4.54

129.54

1.8

1.5

—

(3037121) Protein [Mass/volume] in Urine

769

3046

2.64

128.02

5.5

3.1

610.45

445.72

mg/l

0.96

486

1297

(3048689) Calprotectin [Mass/mass] in Stool

1934

11110

1.90

128.00

2.6

2.4

162.41

137.16

ug/g

1.93

1595

8798

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

257

498

5.26

125.08

2.5

2.4

0.64

0.69

e9/l

0.61

237

477

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

613

2183

2.92

125.04

2.4

2.0

13.70

11.59

mg/l

4.04

572

2037

(3010503) CD19 cells [#/volume] in Blood

241

442

5.55

124.63

2.6

2.3

156.81

450.95

e6/l

0.84

232

427

(40768797) Stomach Pathology biopsy report

2076

12299

1.85

124.37

1.3

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1442

7566

2.05

123.83

9.3

3.2

1.21

1.23

mmol/l

20.40

1362

6359

(3020191) Ethanol [Moles/volume] in Serum or Plasma

270

565

4.88

120.23

2.1

1.3

1.00

1.30

promille

2.09

204

441

(3008295) Osmolality of Serum or Plasma

361

960

3.86

117.71

1.5

1.4

280.60

277.02

mosm/kgh2o

1.83

288

724

(21494890) Protein electrophoresis panel - 24 hour Urine

333

842

4.05

116.49

3.0

1.8

—

(3000093) Morphology [Interpretation] in Blood Narrative

330

831

4.06

116.09

1.2

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

427

1297

3.39

114.01

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

172

248

7.03

113.04

2.6

1.8

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

326

830

4.02

112.96

4.2

3.6

—

(3003434) Protein [Mass/volume] in Pleural fluid

415

1246

3.42

112.85

1.6

1.4

29.10

33.18

g/l

8.01

369

1134

(3003129) Base excess in Capillary blood by calculation

348

929

3.84

112.83

3.7

1.8

0.73

0.55

mmol/l

0.31

326

889

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

1370

7283

2.01

112.73

4.6

2.5

48.97

66.33

ml/min/173m2

46.84

724

3025

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

107

13.17

112.54

2.6

1.8

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

170

247

6.98

110.94

2.5

1.8

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

170

247

6.98

110.94

2.5

1.8

—

(3017354) Segmented neutrophils/Leukocytes in Blood

325

838

3.97

110.65

4.4

3.3

60.67

56.43

2.77

295

701

(3028192) IgG subclass 2 [Mass/volume] in Serum

328

859

3.91

109.26

1.5

1.4

2.49

3.00

g/l

5.43

245

633

(3022493) Free Hemoglobin [Mass/volume] in Plasma

196

336

5.92

108.85

8.1

2.2

65.85

69.02

mg/l

0.24

163

207

(3024139) IgG subclass 3 [Mass/volume] in Serum

327

859

3.89

108.46

1.4

0.39

0.42

g/l

0.58

242

630

(3027135) IgG subclass 1 [Mass/volume] in Serum

327

860

3.89

108.28

1.5

1.4

6.35

6.68

g/l

0.65

245

637

(3052851) Hemolysis interference index of Serum or Plasma

638

2505

2.64

107.71

4.2

3.0

2.45

1.90

index

0.93

375

1273

(3006245) CD3-CD19+ cells/cells in Blood

181

293

6.27

106.52

2.5

2.3

11.35

11.97

0.16

165

274

(3020564) Creatinine [Moles/volume] in Serum or Plasma

10111

93083

2.39

105.84

55.7

19.7

98.45

78.20

umol/l

144.40

10055

91786

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

187

315

6.02

105.74

1.9

1.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

187

315

6.02

105.74

1.9

1.2

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

24.83

105.16

3.3

3.2

—

(4062490) Immunoglobulin typing, IgG

319

843

3.87

104.91

1.5

1.4

—

(3023199) Leukocytes [#/volume] in Pleural fluid

373

1099

3.48

104.40

1.6

1.4

1739.06

3231.63

e6/l

1.01

267

794

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

177

286

6.28

104.36

2.3

2.1

31.83

27.62

2.24

164

274

(40757373) Influenza virus identified in Isolate

124

133

9.42

104.17

1.7

1.6

—

(3007566) Smooth muscle Ab [Titer] in Serum

575

2178

2.73

104.15

1.4

1.3

90.50

154.65

titre

1.18

198

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

159

232

6.94

103.36

1.2

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

149

204

7.39

102.60

1.8

1.4

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

530

1941

2.82

102.36

1.5

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

580

2229

2.69

102.09

1.4

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

581

2236

2.69

101.98

1.4

1.1

—

(3028433) Virus identified in Specimen by Culture

163

248

6.66

101.89

1.4

1.1

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1043

5200

2.11

101.65

3.3

3.4

4.23

4.51

pmol/l

14.74

933

4616

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

8327

72357

1.66

101.63

52.7

18.3

14.28

13.63

235.62

8284

71295

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

286

722

4.04

100.23

1.1

1.0

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

257

599

4.37

100.14

1.2

207.89

168.73

titre

0.25

118

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

198

375

5.36

98.85

1.4

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

255

599

4.34

98.36

1.2

343.33

170.00

titre

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

570

2214

2.66

98.18

1.4

1.1

—

(3000012) Reticulocyte production index

425

1410

3.10

97.99

2.9

1.9

0.92

0.88

0.73

344

890

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

648

2682

2.51

97.92

1.7

1.5

0.64

7.93

iu/ml

1.32

127

542

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

353

1048

3.45

97.62

1.8

1.3

—

(3017704) Immunofixation for Urine

203

398

5.18

97.49

1.7

1.5

—

(3034770) Mitochondria Ab [Titer] in Serum

558

2152

2.68

97.47

1.4

1.2

897.27

932.97

titre

0.05

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1114

5788

2.03

96.91

2.5

2.4

19.56

21.44

au/ml

0.34

548

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

406

1329

3.14

95.77

1.1

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

9992

92060

2.17

95.64

24.3

11.4

25.65

25.62

u/l

0.04

9857

88944

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

344

1018

3.46

95.60

1.8

1.3

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

191

369

5.25

93.27

1.2

1.1

—

0.12

—

(3042631) Mycobacterium sp identified in Specimen

373

1181

3.24

93.01

3.2

2.8

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

341

1025

3.40

92.46

1.9

1.3

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

303

843

3.67

92.46

1.3

1.2

60.66

64.32

u/l

0.41

275

720

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1033

5314

2.04

92.16

1.3

52.80

55.90

au/ml

0.12

364

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

366

1163

3.22

90.72

1.4

1.2

4.78

4.21

u/ml

0.32

174

527

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

9155

82288

1.75

90.33

9.4

6.5

41.93

39.31

mmol/mol

85.49

8676

76330

(44816559) Phosphatidylethanol [Mass/volume] in Blood

724

3271

2.30

89.77

2.1

1.6

0.31

0.28

mg/l

0.59

345

1495

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

367

1186

3.17

88.43

1.4

1.2

4.92

4.30

u/ml

0.18

143

399

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

180

346

5.27

88.40

1.4

1.2

68.04

70.98

0.14

(3013512) EKG study

4247

32398

1.51

88.30

6.0

3.6

0.78

0.77

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

701

3146

2.31

88.25

1.3

1.2

1.09

1.20

u/ml

0.08

272

(3027456) Digoxin [Moles/volume] in Serum or Plasma

526

2078

2.61

87.43

3.7

3.2

0.84

0.79

nmol/l

1.83

403

1691

(3035947) Staphylolysin Ab [Units/volume] in Serum

172

328

5.31

85.23

1.1

3.33

4.11

iu/ml

0.47

(3025468) Yersinia sp identified in Specimen by Organism specific culture

323

988

3.34

85.17

1.8

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

324

993

3.33

85.16

1.8

1.3

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

324

994

3.33

85.02

1.8

1.3

—

(3004451) EKG impression Narrative

214

496

4.38

83.99

1.7

1.2

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

24.71

83.64

5.6

3.5

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

10.30

83.50

3.3

2.8

51.89

19.46

mg/l

1.33

(3028308) Erythrocytes [#/volume] in Pleural fluid

318

981

3.31

82.71

1.6

1.4

50356.79

61426.38

e6/l

0.24

185

565

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

1227

6960

1.86

81.55

1.7

1.5

—

(3044242) Glucose [Moles/volume] in Arterial blood

200

450

4.51

81.51

2.5

1.8

8.42

7.88

mmol/l

1.10

200

450

(3028707) Methadone [Presence] in Urine by Screen method

367

1247

3.01

81.09

2.8

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

291

860

3.45

81.01

1.4

1.3

270.61

386.14

u/l

2.66

276

820

(3000060) B lymphocytes [#/volume] in Blood

137

221

6.27

80.93

2.3

0.17

0.85

e9/l

1.21

118

(3006922) Hepatitis E virus Ab [Presence] in Serum

229

581

4.01

79.71

1.1

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

304

934

3.32

79.58

2.0

1.8

2984.00

1746.34

titre

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

9204

83503

1.70

79.53

40.3

14.9

72.30

79.20

ml/min/173m2

114.09

8827

77051

(3008037) Lactate [Moles/volume] in Venous blood

560

2382

2.42

79.49

5.9

2.8

1.60

1.59

mmol/l

0.06

546

2317

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

10.99

78.87

6.3

5.0

56.35

39.39

ug/min

1.16

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

9.86

78.33

1.4

1.2

95.43

55.24

ng/l

0.92

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2284

15543

1.60

77.59

1.4

1.3

46.44

33.28

iu/ml

0.48

741

4579

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

138

239

5.84

75.87

2.2

1.9

2.03

1.76

ratio

0.61

131

233

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

34.43

75.68

3.8

4.0

—

(3008536) Aspergillus sp Ab [Presence] in Serum

101

126

8.08

75.33

2.8

1.8

—

(3016228) CD19 cells/cells in Blood

155

302

5.19

75.00

2.2

2.0

7.46

8.80

0.62

150

295

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

509

2133

2.45

74.59

1.3

1.2

25.80

11.47

u/ml

—

(21494814) CD8 cells/Lymphocytes in Specimen

155

305

5.14

74.17

2.2

2.0

31.89

30.61

0.36

155

305

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

201

490

4.16

73.86

1.1

—

0.62

—

(3045788) Cell count panel - Pleural fluid

287

894

3.27

73.47

1.6

1.4

—

(3003327) Ova and parasites identified in Stool by Light microscopy

635

2955

2.22

73.02

1.8

1.7

—

(4268621) Lupus anticoagulant assay

270

814

3.38

72.85

2.5

2.2

—

(3045142) Bone marrow Pathology biopsy report

307

1001

3.13

72.83

1.5

1.3

—

(3045414) Leukocytes [Presence] in Urine

1472

9099

1.72

72.47

3.0

2.0

0.01

estimate

0.44

304

1794

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

233

642

3.69

72.13

1.6

1.4

14.80

12.61

u/l

2.90

224

619

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

322

1091

3.01

71.49

1.2

1.1

113.15

116.27

0.88

303

979

(3007461) Platelets [#/volume] in Blood

10138

95231

2.09

71.20

65.3

22.7

242.34

247.22

e9/l

9.74

10045

92961

(3035941) MCH [Entitic mass]

10138

95247

2.08

70.91

64.9

22.6

30.28

30.34

2.75

10083

94025

(3010813) Leukocytes [#/volume] in Blood

10140

95273

2.08

70.91

65.3

22.7

7.36

6.78

e9/l

54.21

10025

92623

(3024731) MCV [Entitic mean volume] in Red Blood Cells

10138

95250

2.08

70.86

65.0

22.7

91.68

91.13

23.86

10086

94027

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

10138

95255

2.08

70.77

67.3

23.1

38.55

40.74

42.60

10082

93993

(3026361) Erythrocytes [#/volume] in Blood

10138

95259

2.08

70.70

65.2

22.7

4.26

4.49

e12/l

277.97

10020

92638

(3000963) Hemoglobin [Mass/volume] in Blood

10138

95274

2.08

70.42

65.9

22.9

127.58

135.18

g/l

307.65

10085

94087

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

173

391

4.48

70.14

21.6

20.6

1495.05

1312.92

nmol/l

2.02

163

378

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

157

330

4.81

69.58

5.0

3.2

1.26

1.31

0.10

157

330

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

134

248

5.46

68.67

5.8

2.5

10.12

10.45

kpa

0.46

134

248

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

134

248

5.46

68.67

5.8

2.5

5.12

4.94

kpa

0.69

134

248

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

234

674

3.53

67.79

2.4

1.7

5.33

3.55

mg/l

3.89

221

644

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

104

8.43

67.20

1.8

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

175

415

4.27

66.72

1.5

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

175

415

4.27

66.72

1.5

1.6

—

(3036782) Glucose [Moles/volume] in Pleural fluid

272

871

3.18

66.53

1.4

1.3

7.34

6.01

mmol/l

8.50

260

805

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

9186

84136

1.62

66.43

6.6

5.2

6.22

5.95

mmol/l

40.20

8563

76610

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

328

1172

2.86

66.15

1.2

1.1

—

(4035726) Immunohistochemistry procedure

1297

7928

1.72

66.08

1.8

1.4

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

263

829

3.23

66.04

1.2

1.1

93.49

96.50

0.88

252

775

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

165

378

4.42

65.78

15.9

14.8

859.67

4252.92

nmol/l

0.49

155

361

(4195642) Thrombophilia screening test

311

1084

2.92

65.64

1.3

1.2

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

13.26

65.55

1.3

1.1

1.35

0.05

u/ml

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

127

235

5.46

65.10

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

101

151

6.74

64.23

1.6

1.3

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2088

14455

1.55

64.19

1.4

1.3

13.75

11.62

u/ml

0.34

716

5491

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

414

1690

2.51

64.11

5.3

1.7

1.06

0.80

nmol/l

5.96

348

1448

(3019832) Treponema pallidum Ab [Presence] in Serum

1235

7518

1.73

63.72

2.0

1.8

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

458

1964

2.39

63.70

1.3

1.2

2.69

3.84

u/ml

0.30

141

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

176

435

4.10

63.53

4.3

4.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

519

2353

2.27

63.45

1.6

1.4

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

228

676

3.42

63.18

1.4

1.3

12.67

15.45

u/l

0.47

207

631

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

113

193

5.91

63.06

1.2

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

483

2130

2.33

63.02

1.2

3.94

3.97

0.02

253

(3016038) Potassium [Moles/volume] in Urine

209

587

3.61

62.91

2.0

1.2

31.65

35.31

mmol/l

1.37

193

503

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

114

197

5.84

62.85

1.2

1.1

—

(3022145) Colonoscopy Study observation

1575

10274

1.62

62.25

1.5

1.4

—

(3047189) Immunofixation for 24 hour Urine

159

371

4.33

61.93

2.2

1.6

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

535

2486

2.21

61.59

1.3

1.2

21.48

37.08

u/ml

1.09

132

(3004716) Salmonella sp identified in Stool by Organism specific culture

729

3820

1.97

60.90

1.4

1.3

—

(4198724) Urine methamphetamine measurement

138

292

4.77

60.71

2.1

2.8

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

184

488

3.82

60.24

1.3

1.2

104.46

87.85

u/l

1.16

162

396

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

216

641

3.42

59.78

1.4

1.2

97.06

112.26

pmol/l

2.62

216

641

(3045424) Erythrocytes [Presence] in Urine

814

4471

1.89

59.03

3.1

2.0

0.00

0.20

estimate

0.55

249

1368

(3026692) Albumin [Mass/volume] in Peritoneal fluid

104

177

5.92

58.27

1.5

1.3

13.55

14.63

g/l

0.49

142

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

503

2334

2.21

58.07

1.4

1.3

5.72

7.80

u/ml

0.61

345

(40768806) Pleura Pathology biopsy report

276

965

2.91

57.93

1.6

—

(3006576) Bicarbonate [Moles/volume] in Blood

119

231

5.20

57.88

9.8

5.0

25.34

24.92

mmol/l

0.43

105

210

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

178

475

3.79

57.77

1.3

1.2

39.45

23.94

u/l

2.09

155

380

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

21.58

57.73

4.2

4.7

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

199

573

3.52

57.71

1.3

1.1

40.26

43.03

mg/l

0.36

169

473

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

502

2334

2.21

57.67

1.3

7.72

5.19

u/ml

0.20

227

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

107

190

5.68

57.36

1.1

1.0

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

144

332

4.38

56.98

2.1

1.7

175.69

145.29

2.92

134

313

(36660697) Celiac disease serology panel - Serum

1147

7045

1.70

56.92

1.2

—

(3019225) pH of Specimen

1380

8904

1.63

56.60

10.3

3.6

7.37

7.35

2.08

1149

6133

(3023487) Leukocytes [#/volume] in Peritoneal fluid

124

255

4.91

56.45

2.4

1.7

555.79

6435.72

e6/l

0.93

170

(3044927) Protein electrophoresis panel - Urine

252

854

3.00

55.94

1.3

1.1

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

14.91

55.32

8.4

11.3

151.39

158.36

e6/l

0.03

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

182

509

3.62

55.17

1.4

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

183

517

3.58

54.64

1.4

1.2

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

189

546

3.51

54.55

1.2

1.1

298.68

279.36

mg/l

0.35

170

477

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

2060

14671

1.50

54.31

1.8

1.6

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

502

2394

2.15

54.07

1.3

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

103

188

5.52

53.63

1.2

1.1

—

(3011288) Drugs identified in Urine by Screen method Nominal

457

2106

2.22

53.63

3.5

2.8

—

(3051651) Icteric interference index of Serum or Plasma

169

459

3.72

53.50

4.8

2.9

0.83

0.95

index

0.52

169

451

(3000475) Leukocytes [#/volume] in Synovial fluid

466

2169

2.20

53.36

1.8

1.6

14032.34

12884.31

e6/l

0.28

353

1487

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

155

398

3.94

53.15

1.2

1.1

1746.80

1471.99

miu/ml

1.97

155

398

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

286

1073

2.71

52.58

1.1

1.61

1.49

g/l

3.99

263

971

(3018851) Theophylline [Moles/volume] in Serum or Plasma

10.41

52.54

1.8

1.9

47.11

47.52

umol/l

0.03

(3027923) C peptide [Moles/volume] in Serum or Plasma

165

449

3.72

52.09

1.5

1.37

1.19

nmol/l

1.02

115

328

(3039162) Centromere protein B Ab [Units/volume] in Serum

275

1027

2.72

51.02

1.3

1.2

68.85

51.52

u/ml

0.41

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

14.43

51.01

3.6

3.7

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

443

2058

2.20

50.95

2.9

2.3

192.47

98.82

ug/min

2.29

264

1204

(3038515) Glucose [Moles/volume] in Venous blood

439

2032

2.21

50.95

6.5

2.9

7.48

7.52

mmol/l

0.11

425

1980

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

169

476

3.59

50.72

1.6

1.5

8.62

6.70

u/l

0.63

136

373

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

104

202

5.19

50.59

2.8

1.49

1.91

ratio

2.05

183

(40768441) Liver Pathology biopsy report

195

605

3.26

50.31

2.2

1.3

—

(3016244) Insulin [Units/volume] in Serum or Plasma

162

446

3.67

50.29

3.2

21.83

25.15

mu/l

0.57

151

414

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

8.58

50.24

1.2

1.1

—

(3011985) Renin [Units/volume] in Plasma

302

1192

2.58

50.17

1.8

1.5

81.16

63.17

mu/l

0.52

276

1060

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

8780

80783

1.47

49.99

5.4

4.3

1.41

1.26

mmol/l

44.46

8115

73545

(40761536) Microorganisms panel - Urine sediment

1150

7302

1.64

49.90

8.5

3.8

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

215

714

3.05

49.48

1.5

1.3

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1463

9862

1.56

49.35

3.4

4.3

7.43

30.10

ug/l

5.69

1199

8112

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

174

5.50

49.30

1.2

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

491

2407

2.09

49.18

2.6

2.1

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

158

435

3.67

49.06

1.2

1.1

39.32

22.85

u/l

1.75

148

378

(4027681) Cerebrospinal fluid IgG ratio and IgG index

154

417

3.73

48.99

1.4

1.2

0.52

0.62

ratio

2.10

233

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

543

2768

2.01

48.88

3.1

2.3

4909.86

5998.33

u/l

0.35

180

1071

(3049717) Cytology report of Urine Cyto stain

680

3741

1.87

48.84

2.5

2.8

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

153

414

3.73

48.72

1.2

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

19.06

48.34

1.2

1.1

—

(40757494) Bilirubin.total [Moles/volume] in Blood

154

421

3.70

48.32

2.8

2.1

27.69

46.52

umol/l

0.56

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

836

4917

1.76

48.14

2.5

2.4

—

(3035880) pH of Pleural fluid

161

456

3.57

47.93

1.4

1.3

7.45

7.40

2.80

123

326

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

106

220

4.86

47.78

2.3

1.5

18191.58

16406.00

e6/l

0.06

120

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

174

520

3.38

47.69

1.2

1.1

—

(3041354) Potassium [Moles/volume] in Venous blood

281

1100

2.60

47.48

4.0

2.0

4.14

4.07

mmol/l

1.63

281

1091

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

283

1117

2.57

47.02

1.2

1.1

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

138

357

3.90

46.87

2.8

1.9

2.04

1.89

umol/l

0.94

131

330

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

157

444

3.57

46.85

1.2

1.1

102.79

81.06

u/l

1.36

147

390

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

212

724

2.97

46.47

1.2

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

289

1159

2.53

46.46

1.2

13.33

8.60

u/ml

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

108

234

4.65

46.24

1.3

1.2

13.35

20.55

0.49

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

765

4437

1.78

46.17

1.2

1.1

55.55

7.00

u/ml

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

165

5.43

45.61

1.4

1.2

—

(21494434) Karyotype in Bone marrow

220

776

2.87

45.49

1.3

1.2

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

133

343

3.91

45.38

1.2

1.1

166.84

471.33

ng/l

0.82

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

184

5.14

45.35

13.9

6.2

5.83

5.99

kpa

0.88

164

(3024666) Lithium [Moles/volume] in Serum or Plasma

139

370

3.79

45.35

13.6

12.8

0.61

0.62

mmol/l

0.09

131

340

(3009871) Measles virus Ab [Titer] in Serum

112

254

4.45

45.32

1.4

1.7

2408.00

3111.67

titre

0.60

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

362

1631

2.26

44.85

1.3

72.47

33.47

u/l

2.26

319

1403

(4024509) Urine culture

753

4403

1.76

44.15

2.6

1.9

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

124

313

4.00

43.60

2.7

2.5

58.63

52.67

umol/l

1.10

102

279

(40771922) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by based on 1.73 sq M

10.72

43.47

1.4

1.2

0.87

1.59

ml/s/173m2

2.96

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

462

2321

2.03

43.27

1.3

214.56

228.64

miu/ml

0.26

126

1041

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

386

1816

2.17

43.00

1.3

1.2

51.36

43.62

u/ml

0.35

174

(3033705) Calcium.ionized [Moles/volume] in Venous blood

269

1087

2.51

42.58

4.2

2.0

1.19

1.20

mmol/l

1.07

269

1078

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

7980

72803

1.37

42.46

55.3

19.3

329.97

332.35

g/l

87.62

7951

72315

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

283

1178

2.44

42.03

3.0

2.8

70.82

1405.46

u/ml

1.01

277

1167

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

9275

86908

1.48

41.96

7.0

5.8

2.39

2.65

mmol/l

147.13

8684

80294

(3021387) Prolactin [Units/volume] in Serum or Plasma

510

2683

1.95

41.88

2.0

1.7

346.95

292.37

mu/l

2.27

461

2457

(3051611) Lipemic interference index of Serum or Plasma

231

874

2.68

41.83

4.8

2.9

15.52

13.33

index

1.80

169

452

(3003694) ABO and Rh group [Type] in Blood

3218

25808

1.35

41.38

1.6

1.4

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

207

4.67

41.38

1.3

1.1

17.86

11.74

pmol/l

0.76

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

106

248

4.31

41.25

2.3

1.8

211.46

164.91

2.71

236

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

223

837

2.70

41.02

1.3

1.61

1.47

nmol/l

0.92

207

751

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

179

599

3.02

40.71

1.2

—

(3010838) Calcium [Moles/time] in 24 hour Urine

324

1454

2.27

40.54

1.7

1.8

4.40

5.01

mmol/24h

2.52

280

1275

(3020393) Adenovirus Ag [Presence] in Stool

100

6.53

40.30

1.8

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

184

630

2.95

40.20

1.2

—

(3018333) Ribosomal P Ab [Presence] in Serum

175

583

3.03

40.12

1.2

—

(3026389) Candida sp identified in Specimen by Organism specific culture

293

1265

2.35

40.12

1.5

1.4

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

156

5.22

39.83

1.7

1.2

245.82

27.32

g/l

0.49

116

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

178

602

2.99

39.75

1.1

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

150

459

3.30

39.65

2.1

1.5

15.52

22.77

umol/l

3.43

143

421

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

187

651

2.91

39.65

1.2

—

(3012898) Urea [Moles/volume] in Urine

8.40

39.39

1.4

1.5

130.12

186.33

mmol/l

2.08

(3016879) Cocaine [Presence] in Urine

530

2882

1.88

39.36

2.7

2.0

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

284

1229

2.35

38.69

1.4

1.3

0.20

0.23

nmol/l

0.19

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

439

8088

0.52

38.63

1.8

1.9

3.49

ratio

0.04

338

6208

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

181

629

2.91

38.52

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

181

629

2.91

38.52

1.2

—

(3012565) Volume of 24 hour Urine

136

401

3.42

38.15

2.6

2.1

1642.92

1993.46

3.30

120

352

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

9110

85389

1.43

38.05

6.3

5.1

4.27

4.55

mmol/l

119.36

8530

79182

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

172

585

2.97

38.05

1.3

1.5

14.83

12.47

umol/l

3.46

162

546

(3023511) Choriogonadotropin [Units/volume] in Urine

297

1320

2.29

38.03

1.6

1.3

—

(3014271) Vancomycin [Susceptibility]

147

457

3.25

37.89

3.5

2.8

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

264

1119

2.39

37.70

1.3

799.52

325.58

pmol/l

0.65

224

933

(3022621) pH of Urine by Test strip

1110

7448

1.55

37.57

3.9

2.7

6.08

6.06

0.29

844

5111

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

276

1195

2.34

37.56

1.4

1.3

3.61

3.92

nmol/l

0.03

266

1156

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

590

3369

1.79

37.40

3.0

3.4

1208.23

1877.31

u/ml

0.26

509

2896

(3000764) Benzodiazepines [Presence] in Urine

553

3099

1.83

37.30

2.7

2.0

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

175

610

2.90

37.05

1.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

164

4.91

36.66

14.7

6.3

6.62

5.15

kpa

2.75

164

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

118

5.71

36.32

1.6

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

118

5.71

36.32

1.6

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

118

5.71

36.32

1.6

1.0

—

(3023383) Lactate [Moles/volume] in Pleural fluid

103

262

3.96

35.90

1.4

1.3

2.95

3.62

mmol/l

1.35

244

(3027008) Opiates [Presence] in Urine

549

3113

1.80

35.61

2.6

1.9

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

249

1055

2.39

35.61

1.4

1.3

0.20

0.19

nmol/l

0.57

204

850

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

9038

84810

1.41

35.55

6.1

5.0

1.37

1.45

mmol/l

64.07

8414

78128

(3028300) Cannabinoids [Presence] in Urine

550

3122

1.80

35.55

2.7

2.0

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

143

458

3.15

35.12

1.5

9.12

9.89

ug/l

0.12

136

414

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

6.24

35.03

1.2

47.52

57.51

0.59

(3008116) Ketones [Moles/volume] in Urine by Test strip

167

4.76

34.92

2.0

1.4

0.41

0.32

mmol/l

—

(21494755) Public health laboratory ask at order entry panel

334

6505

0.50

34.83

1.3

1.4

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

251

3.97

34.67

2.8

2.7

30.07

27.82

umol/l

0.82

195

(3044007) Cell count panel - Peritoneal fluid

221

4.19

34.65

2.4

1.6

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

8.10

34.53

1.3

1.1

1.28

1.49

iu/ml

0.32

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

106

283

3.77

34.53

1.5

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

6.61

33.92

1.1

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

237

1006

2.39

33.77

1.8

1.5

67.31

56.80

4.15

166

615

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

6.65

33.48

1.1

—

(3016750) Collection duration of Urine

142

467

3.07

33.36

2.9

2.0

497.61

498.36

min

0.03

115

338

(3009214) Lutropin [Units/volume] in Serum or Plasma

444

2409

1.88

33.18

1.5

1.4

9.33

9.43

u/l

0.06

352

1897

(3034426) Prothrombin time (PT)

247

3.91

32.96

1.3

1.2

28.58

28.31

0.14

247

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

127

396

3.23

32.64

1.2

1.1

1.15

1.16

u/l

0.02

163

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

125

387

3.26

32.50

1.3

1.2

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

5.88

32.49

1.2

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

12.95

32.26

2.1

1.0

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

108

308

3.53

31.95

1.2

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

6.07

31.80

1.2

1.1

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

307

5955

0.50

31.53

1.6

1.7

3.35

3.43

mmol/l

0.52

202

4098

(3027944) Amphetamines [Presence] in Urine

529

3075

1.76

31.51

2.7

1.9

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

7.85

31.45

4.9

3.2

1.23

1.18

mg/l

0.07

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

231

3.92

31.03

1.2

1.1

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

178

690

2.61

30.81

2.8

2.6

17.89

18.84

nmol/l

0.61

171

658

(3026051) Granulocytes/Leukocytes in Pleural fluid

182

4.31

30.55

1.4

1.3

24.11

23.26

0.09

154

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

188

4.23

30.17

1.2

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

201

4.10

30.11

1.4

1.2

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

116

360

3.25

30.08

1.6

1.4

3706000.00

901052.50

iu/ml

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

160

597

2.71

29.89

1.4

1.13

2.85

u/ml

1.85

111

352

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

233

3.84

29.86

1.1

1.2

86.17

88.12

0.19

121

(3004775) Volume in Urine collected for unspecified duration

173

674

2.59

29.66

2.7

2.2

703.75

644.40

0.83

129

438

(3020961) Endomysium IgA Ab [Titer] in Serum

659

4135

1.63

29.48

1.2

1.1

255.67

187.21

titre

0.16

126

(3010144) Erythrocytes [#/volume] in Synovial fluid

191

783

2.47

29.43

1.5

1.4

121391.69

180821.14

e6/l

0.51

124

509

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

269

1280

2.13

29.18

1.1

131.29

9032.80

iu/ml

0.55

269

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

156

583

2.70

29.06

1.1

297.36

285.40

mg/l

1.01

143

535

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

225

3.84

28.90

1.1

1.3

87.82

86.33

0.11

120

(3005532) Lymphocytes/Leukocytes in Pleural fluid

103

305

3.40

28.80

1.5

1.4

58.04

65.91

1.23

258

(3004616) Nuclear Ab [Presence] in Serum

229

1027

2.26

28.78

1.3

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

294

1458

2.04

28.58

2.0

1.6

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

183

746

2.48

28.55

1.7

1.6

30.72

23.76

u/ml

0.81

143

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

232

3.77

28.46

1.2

1.3

106.94

101.96

0.48

215

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

203

873

2.35

28.15

1.2

31.90

39.49

u/ml

—

(3032057) Clostridioides difficile [Presence] in Stool

145

4.57

27.91

2.0

1.5

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

107

5.26

27.86

1.4

1.2

66.17

307.67

u/l

0.42

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

100

300

3.36

27.42

1.4

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

138

500

2.78

27.31

1.6

1.5

6.66

5.81

u/l

0.27

116

428

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

7.90

27.22

1.2

0.46

0.57

iu/ml

0.14

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

118

393

3.02

27.21

1.1

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

345

1841

1.90

27.16

2.7

1.9

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

165

657

2.53

27.08

1.4

1.3

861.43

422.67

titre

0.59

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

121

412

2.96

26.84

2.6

2.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

163

651

2.53

26.59

2.3

1.7

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

276

1376

2.03

26.47

1.2

1.1

22.49

16.40

au/ml

0.37

288

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

161

642

2.53

26.36

1.4

1.3

38.00

64.42

titre

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

6.58

26.32

3.6

2.0

—

(3000330) Specific gravity of Urine by Test strip

756

5032

1.54

26.23

5.4

3.4

1.02

ratio

1.90

708

4531

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

255

3.51

26.22

2.3

2.4

149.65

141.76

nmol/l

0.28

226

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

7.28

25.40

1.1

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

7.06

25.39

1.7

2.57

1.42

mg/l

0.45

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

130

478

2.74

25.06

2.7

1.7

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

142

4.39

24.93

1.6

1.5

85.55

119.13

ug/l

1.81

120

(21491868) Cryoglobulin [Mass/volume] in Serum

294

3.25

24.82

1.3

1.2

0.09

0.39

g/l

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

128

4.55

24.43

1.4

1.2

1.32

1.54

mmol/l

0.10

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

7.08

24.12

1.7

2.37

1.58

mg/l

0.24

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

7.08

24.12

1.7

2.22

2.65

mg/l

0.14

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

7.08

24.12

1.7

2.44

1.85

mg/l

0.20

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

7.08

24.12

1.7

2.81

4.76

mg/l

0.62

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

7.08

24.12

1.7

2.56

3.82

mg/l

0.58

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

7.08

24.12

1.7

1.49

1.85

mg/l

0.23

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

7.08

24.12

1.7

1.66

1.19

mg/l

0.18

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

7.08

24.12

1.7

0.86

1.16

mg/l

0.32

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

7.08

24.12

1.7

4.18

2.02

mg/l

0.58

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

142

4.31

24.03

1.5

1.2

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

122

444

2.77

24.00

1.9

1.60

2.87

u/field

1.32

299

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

178

782

2.30

23.57

1.4

—

(3042847) Granulocytes/Leukocytes in Cerebral spinal fluid

6.31

23.49

1.3

1.1

34.92

17.17

0.77

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

5.12

23.27

3.5

4.7

38.05

39.98

umol/l

0.23

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

131

508

2.60

22.78

1.4

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

119

441

2.72

22.64

1.1

1.2

1.10

1.06

ratio

1.70

348

(37208534) Antinuclear antibody arbitrary concentration in serum

247

3.34

22.41

1.0

1.1

—

(3042517) Benzodiazepines panel - Urine

6.29

22.22

2.1

2.0

—

(40768443) Skin Pathology biopsy report

640

4281

1.53

21.65

1.3

1.2

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

199

948

2.12

21.63

3.1

2.3

9.76

7.75

umol/l

0.44

151

702

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

127

500

2.56

21.44

1.1

0.34

11.33

nmol/l

2.62

102

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

803

5636

1.46

21.43

1.3

1.2

107.22

135.24

u/ml

1.32

270

2026

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

147

4.03

21.30

1.2

90.10

75.05

1.88

(3041918) Cholesterol [Moles/volume] in Pleural fluid

175

3.73

21.07

1.4

1.2

1.63

1.70

mmol/l

0.14

113

(3002256) Pathology report gross observation

1565

12293

1.32

21.01

1.4

1.3

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

222

1114

2.01

20.99

1.1

3.64

3.04

0.31

159

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

243

3.27

20.91

1.2

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

128

4.23

20.83

1.5

1.2

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

389

2332

1.69

20.77

1.9

6.27

6.57

iu/l

0.03

146

910

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

245

3.24

20.64

1.6

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.85

20.54

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

5.92

20.38

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

253

1345

1.90

20.24

1.3

1.1

—

(4015189) Microbial culture of sputum

204

3.45

20.19

3.0

2.2

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

163

739

2.22

20.10

1.2

96.38

60.48

u/ml

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

111

4.43

20.03

1.2

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

225

1155

1.97

19.97

1.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

252

1345

1.89

19.92

1.3

1.1

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

146

3.92

19.84

1.2

78.41

71.00

0.47

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

149

658

2.28

19.57

1.6

1.2

—

(3043410) Blood group antigens tested for on Red Blood Cells

223

3.29

19.56

2.3

1.8

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

167

775

2.17

19.45

1.9

1.5

22.65

33.29

3.81

118

454

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

4.79

19.35

1.4

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

6.13

19.34

1.2

1.1

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

20.05

19.01

6.5

6.9

—

(3034459) Mononuclear cells/Leukocytes in Pleural fluid

4.90

18.92

1.5

1.3

77.61

69.50

0.84

(3038026) Centromere Ab [Units/volume] in Serum

143

631

2.28

18.84

1.2

58.53

48.24

u/ml

—

(3018562) Neutrophils/Leukocytes in Cerebral spinal fluid

7.31

18.63

1.2

41.15

38.62

0.08

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

181

3.50

18.60

1.3

1.2

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

274

2.97

18.32

1.4

1.3

0.32

0.30

g/l

1.58

221

(3002079) Sodium [Moles/time] in 24 hour Urine

362

2.69

18.29

1.2

1.3

145.40

168.73

mmol/24h

1.87

362

(3037577) Monocytes/Leukocytes in Cerebral spinal fluid

7.83

18.26

1.2

1.3

18.60

11.77

0.48

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

340

2.75

18.25

1.1

4.08

16.08

u/ml

0.70

(3046861) Legionella sp Ag [Presence] in Urine

6.26

17.98

1.1

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

231

1243

1.88

17.86

2.0

1.9

21.11

24.63

ug/l

0.53

223

1216

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

113

4.17

17.84

1.1

1.4

8.73

295564.61

nmol/l

0.72

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

145

3.74

17.63

1.2

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

298

2.83

17.46

1.2

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

387

2432

1.61

17.23

6.5

4.1

—

(3001893) Eosinophils/Leukocytes in Pleural fluid

273

2.91

17.23

1.6

1.4

2.70

2.77

0.03

236

(3017315) Amylase [Enzymatic activity/volume] in Urine

109

444

2.47

17.22

1.3

157.83

446.47

u/l

2.44

411

(3023323) Follitropin [Units/volume] in Serum or Plasma

481

3188

1.53

17.00

1.5

1.4

23.56

25.05

iu/l

0.44

387

2669

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

298

2.80

16.88

1.1

1.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1397

11115

1.30

16.79

15.8

6.7

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

272

2.88

16.75

1.3

1.4

17.78

14.69

pmol/l

0.89

220

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

379

2.57

16.73

1.8

1.6

3.33

6.88

nmol/l

1.17

310

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

343

2113

1.64

16.56

1.1

6.35

8.07

eliau/ml

0.28

235

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

157

759

2.08

16.53

2.5

2.1

1.75

1.55

u/field

0.27

406

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

112

2465

0.45

16.49

1.1

0.71

0.63

ratio

0.32

322

(3000919) Neutrophils/Leukocytes in Pleural fluid

243

2.98

16.39

1.6

1.4

24.19

18.25

0.97

224

(1761868) Lipid panel - Serum or Plasma

2757

31732

0.82

16.37

3.9

3.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

169

3.39

16.08

2.2

2.7

321.25

243.70

ug/l

0.08

169

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

477

3194

1.52

16.08

1.6

18.87

19.12

u/ml

0.02

737

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

694

5012

1.41

15.80

2.6

2.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

3743

33286

1.19

15.62

5.2

5.9

2.61

3.63

ug/l

2.23

3383

30006

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

261

2.85

15.59

1.4

1.3

110.94

109.46

0.16

231

(3004437) Lymphocytes/Leukocytes in Peritoneal fluid

5.27

15.57

3.8

2.0

58.86

63.71

0.26

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

19.20

15.51

7.5

5.8

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

112

485

2.32

15.50

1.1

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

204

3.10

15.43

1.4

1.3

28.53

37.90

1.31

139

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

253

2.86

15.28

1.4

1.3

147.46

134.63

nmol/l

0.24

193

(3019768) Coxiella burnetii Ab [Presence] in Serum

6.06

15.10

1.3

1.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

266

2.79

15.07

1.3

1.2

164.85

358.60

ug/l

0.55

151

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1035

8028

1.32

14.93

2.5

2.1

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

193

3.12

14.87

1.5

1.6

0.33

0.38

ug/l

0.56

114

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

11.28

14.72

1.9

1.0

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

242

2.86

14.71

1.1

1.2

1035.29

925.49

titre

0.29

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

102

436

2.35

14.57

1.6

1.3

3.71

4.92

umol/l

3.21

393

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

100

424

2.37

14.55

2.1

2.4

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

4.26

14.50

1.2

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

106

3.88

14.17

1.3

1.2

—

(44786800) Granulocytes/Leukocytes in Body fluid

4.10

14.15

1.3

31.83

24.84

0.47

(3002621) Streptococcal DNAse B [Units/volume] in Serum

4.05

13.95

1.0

1.1

181.43

332.09

u/ml

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

10.02

13.91

26.2

4.2

107.22

103.30

g/l

0.44

(3024869) Neuronal Ab [Presence] in Serum

155

3.30

13.89

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

588

4221

1.42

13.86

2.4

2.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

4.20

13.84

1.2

1.1

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

280

2.65

13.70

2.0

2.9

1.55

1.10

ug/l

0.84

264

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

626

4556

1.40

13.63

1.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

10.02

13.42

2.5

1.1

—

(3014891) Appearance of Pleural fluid

115

3.66

13.41

2.2

1.4

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1102

8742

1.29

13.41

2.6

2.2

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

5.20

13.40

1.6

1.2

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

134

3.44

13.39

8.8

6.8

10.39

10.60

0.18

134

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

123

3.51

12.88

1.7

2.6

1.07

1.83

mmol/l

0.98

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

128

3.45

12.85

1.6

1.4

16.06

10.24

0.40

(3024316) Viscosity of Plasma

5.96

12.57

2.1

1.4

1.68

1.69

mpas

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

181

2.99

12.54

1.6

1.2

1.17

1.18

mmol/l

0.44

181

(3002619) Bacteria identified in Specimen by Culture

236

2.72

12.49

1.3

1.2

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

4.01

12.34

1.0

0.02

0.51

u/ml

0.83

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

11.60

12.28

1.1

1.0

—

(40765096) Chromosome analysis panel by Banding

285

2.54

12.22

1.2

1.1

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

15.86

12.11

2.2

4.4

—

(3013336) Amino acids [Identifier] in Serum or Plasma

8.64

11.97

4.8

2.0

—

(40768795) Lymph node Pathology biopsy report

168

934

1.81

11.86

1.3

1.2

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

3.83

11.60

1.2

1.1

19.58

21.70

u/l

0.25

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

165

920

1.81

11.55

1.7

465.73

343.38

mu/l

1.06

135

733

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

235

2.65

11.51

1.1

1.2

4.20

7.45

u/ml

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

106

3.50

11.10

1.2

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

146

796

1.85

11.02

4.5

2.9

137.38

42.39

mg/l

2.45

118

580

(46234826) Other cells/Leukocytes in Peritoneal fluid by Manual count

5.01

10.97

3.8

2.0

9.25

18.38

0.84

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

4.41

10.70

1.1

0.09

0.03

u/ml

0.49

(3018133) Calcium [Moles/volume] in Urine

187

2.79

10.70

2.3

2.1

2.37

2.76

mmol/l

0.71

167

(3006442) Creatine [Moles/volume] in Serum or Plasma

110

553

2.00

10.59

2.2

1.4

104.74

82.54

umol/l

1.65

110

553

(3028717) Thiamine [Mass/volume] in Blood

115

3.31

10.50

1.3

1.2

65.79

63.93

ug/l

0.18

115

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

212

2.65

10.45

3.7

6.9

61.64

72.08

1.49

168

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

4.27

10.28

6.9

4.4

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

4.90

10.24

1.0

—

(3001019) Free T4 and TSH panel - Serum or Plasma

218

3414

0.63

10.23

1.7

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

999

8096

1.26

10.14

2.7

2.2

11.84

12.92

nmol/l

3.46

886

7255

(3034891) Synovial lining cells/cells in Synovial fluid

408

2.14

10.10

1.9

1.4

2.04

4.35

1.59

(40758292) HTLV I+II Ab panel - Serum

146

2.95

9.84

1.4

1.3

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

318

2.27

9.69

1.0

1.1

97.16

94.43

0.21

242

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

251

2.44

9.63

2.7

3.1

110.20

121.61

au/ml

0.07

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

3.49

9.59

1.2

1.3

89.86

84.20

ug/l

0.09

(3004446) Plasmodium sp identified in Blood by Light microscopy

4.29

9.56

1.8

2.7

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

178

2.70

9.37

1.4

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

21.69

9.34

1.2

1.0

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

255

2.40

9.32

1.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

184

1139

1.63

8.92

2.3

2.0

20.69

25.20

mg/l

1.05

392

(3044009) aPTT.lupus sensitive (LA screen)

4.19

8.90

1.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

107

3.18

8.87

1.1

—

(3022640) Eosinophils/Leukocytes in Cerebral spinal fluid

7.93

8.83

1.1

1.2

3.21

0.36

0.86

(3033086) Enterovirus Ab [Titer] in Serum

8.58

8.77

1.0

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

145

2.83

8.76

2.1

1.9

—

(3017509) Phencyclidine [Presence] in Urine

3.77

8.76

2.3

1.5

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

288

1982

1.47

8.65

2.7

3.3

397.10

775.34

u/ml

0.86

256

1808

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

104

3.18

8.60

1.3

1.5

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

3.97

8.31

1.7

1.6

14.21

13.80

pmol/l

0.06

(3018738) Hemoglobin F/Hemoglobin.total in Blood

4.08

8.24

4.9

2.4

20.06

4.18

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

173

2.61

8.23

1.3

1.01

82.15

mg/l

1.19

129

(3001686) Cold agglutinin [Titer] in Serum or Plasma

174

2.59

8.14

1.3

1.4

67.20

202.36

titre

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

278

2.24

8.12

3.4

4.1

7.91

8.46

mg/l

0.26

225

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

3.23

8.05

1.0

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

280

2.22

7.99

1.8

1.4

96.12

278.16

nmol/24h

1.04

280

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

6.56

7.86

1.1

1.0

—

(3008898) HLA-B27 [Presence]

364

2662

1.38

7.83

1.1

—

(3019174) dRVVT (LA screen)

4.04

7.78

1.1

1.2

—

(3024263) Appearance of Synovial fluid

417

1.97

7.77

1.7

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

154

946

1.64

7.76

1.4

24.24

24.36

u/l

0.01

128

782

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

6.93

7.75

1.2

1.0

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

4.51

7.63

1.1

1.7

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

4.51

7.63

1.3

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2940

26759

1.14

7.63

4.5

4.8

22.86

22.25

1.13

1397

13916

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

157

2.62

7.59

2.1

1.8

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

177

2.49

7.38

2.2

2.4

7.43

7.74

mmol/l

0.19

109

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

109

2.94

7.36

1.1

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

8.34

7.30

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

116

2.85

7.19

1.2

1.0

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

169

1083

1.57

7.19

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

1500

0.54

7.17

1.5

1.6

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

444

1.90

7.14

2.0

2.1

107.86

87.68

ug/min

0.13

116

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

3.49

6.97

1.1

1.2

—

(3036670) Protein [Mass/volume] in Synovial fluid

271

2.15

6.93

1.1

1.2

39.43

39.05

g/l

0.07

126

(3051387) C reactive protein [Mass/volume] in Capillary blood

277

1977

1.41

6.93

5.9

3.3

29.24

28.20

mg/l

0.21

196

1387

(3033923) Metanephrine [Moles/time] in 24 hour Urine

159

2.52

6.90

1.1

0.71

0.70

umol/24h

0.06

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

13.76

6.88

1.1

1.0

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

746

6114

1.24

6.87

1.2

1.3

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

247

2.19

6.81

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

247

2.19

6.81

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

247

2.19

6.81

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

247

2.19

6.81

1.1

—

(3016135) IgD [Mass/volume] in Serum

9.30

6.77

1.2

49.13

125.44

mg/l

0.36

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

161

2.49

6.73

3.5

5.1

43.05

64.24

u/l

0.74

153

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

510

4008

1.29

6.73

3.2

3.7

48.14

76.11

u/ml

1.82

483

3853

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

104

2.89

6.72

1.9

2.5

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

132

2.66

6.71

1.8

36.76

48.07

pmol/l

0.47

106

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

3.50

6.70

1.8

2.2

—

(4212803) Bone marrow aspirate examination

3.14

6.69

1.1

1.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

251

2.16

6.56

1.1

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

4.15

6.54

1.2

13164.63

2848.97

ng/l

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

169

1108

1.53

6.54

1.4

1.5

0.24

0.35

nmol/l

2.37

125

856

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

373

1.94

6.54

2.3

1.8

37.83

40.12

g/l

2.58

373

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

5.67

6.43

1.3

1.5

520.95

409.48

nmol/l

0.29

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

3.20

6.40

1.0

1.2

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

3.83

6.25

1.4

1.2

0.07

0.06

g/l

0.18

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

263

2.10

6.24

2.5

2.3

8.13

9.65

mg/l

1.41

225

(44806071) Cardiolipin IgM antibody measurement

110

2.73

6.09

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

293

2161

1.37

6.07

1.3

—

(4146454) Self-monitoring of blood glucose

155

1015

1.53

6.06

3.0

2.7

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

3.45

5.99

4.0

1.9

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

3.34

5.98

1.1

1.0

—

(3020618) Glucose [Moles/volume] in Synovial fluid

6.01

5.98

1.0

5.43

5.84

mmol/l

—

(3020491) Glucose [Moles/volume] in Blood

104

621

1.68

5.95

2.1

1.9

7.56

6.74

mmol/l

1.02

427

(44813793) Dust mix specific IgE antibody measurement

101

599

1.69

5.93

1.1

—

(3032641) Amino acids panel - Urine

9.17

5.78

1.3

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

102

2.75

5.77

1.7

1.6

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

3.91

5.70

1.1

1.3

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

182

2.26

5.62

1.2

1.3

265.70

271.23

pmol/l

0.06

137

(3012494) Peanut IgE Ab [Units/volume] in Serum

234

2.10

5.62

1.0

1.1

0.63

20.01

u/ml

0.79

137

(3038177) Helicobacter pylori Ab [Presence] in Serum

187

1303

1.44

5.43

1.2

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

3900

36605

1.10

5.43

2.3

1.9

1.50

1.33

mmol/l

16.75

3380

30382

(3004347) Hepatitis D virus Ab [Presence] in Serum

7.06

5.43

1.0

1.1

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

2.95

5.40

2.5

2.7

0.76

0.62

ug/l

0.88

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

283

2122

1.34

5.33

2.1

1.9

189.84

203.03

pmol/l

1.25

269

1999

(3045683) HLA typing for celiac disease panel - Blood or Tissue

467

1.74

5.31

1.0

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

3.28

5.29

1.2

1.0

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

227

2.08

5.25

1.6

1.9

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

358

2781

1.30

5.25

2.0

1.8

41.48

42.32

nmol/l

0.26

349

2699

(37021550) Renin [Units/volume] in Plasma --upright

169

2.25

5.21

1.4

1.3

141.39

68.10

mu/l

0.55

124

(3033099) Centromere Ab [Titer] in Serum

189

2.17

5.16

1.0

1.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

600

1.64

5.16

1.1

11.60

9.84

iu/ml

0.20

152

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

3.22

5.16

1.2

1.1

9.21

12.32

u/l

0.27

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

7.34

5.13

1.1

—

mmol/l

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

115

2.53

5.11

1.0

1.1

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

127

2.45

5.10

1.5

1.6

0.18

0.17

nmol/l

0.07

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

2.72

5.09

1.1

1.0

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

415

1.76

5.05

9.0

5.6

74.33

947.02

u/ml

0.98

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

460

1.72

5.03

5.5

2.3

224.58

199.08

u/l

1.33

453

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

10.01

5.02

1.7

1.0

—

(36303858) Crystals [Presence] in Urine

6.88

4.94

1.3

1.2

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

154

2.28

4.94

1.1

—

(3007463) Buprenorphine [Presence] in Urine

5.20

4.76

12.9

4.7

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

135

908

1.49

4.75

1.6

1.5

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

190

2.11

4.71

2.0

1.7

66.94

160.17

au/ml

—

(3035320) C reactive protein [Mass/volume] in Body fluid

114

746

1.53

4.58

3.9

2.6

23.02

31.07

mg/l

2.22

530

(3000285) Sodium [Moles/volume] in Blood

186

2.10

4.55

1.4

1.2

137.91

138.67

mmol/l

0.47

151

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

4.82

4.49

1.3

1.1

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

148

2.23

4.48

1.1

0.26

2.90

u/ml

0.89

130

(3033942) Copper [Moles/time] in 24 hour Urine

4.25

4.31

1.4

1.1

1.50

0.51

umol/24h

—

(3006270) Folate [Moles/volume] in Blood

112

746

1.51

4.18

1.2

316.09

348.40

nmol/l

0.86

599

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2.63

4.05

1.5

1.3

17.67

13.55

nmol/l

—

(4281824) Cell count and differential, peritoneal fluid

125

864

1.45

3.91

1.4

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

565

1.56

3.91

1.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

233

1.89

3.90

1.7

10.74

9.29

ug/l

0.94

233

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.63

3.89

1.9

4.5

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

3.79

3.88

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

113

2.30

3.84

1.6

1.7

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

3.06

3.80

1.1

1.0

0.31

0.28

u/ml

0.05

(3013945) Hepatitis B virus e Ab [Presence] in Serum

3.59

3.69

1.1

1.6

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

3.00

3.68

1.1

—

(3049233) Organic acids panel - Urine

5.63

3.65

1.2

1.3

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

551

1.55

3.65

1.1

11.42

19.06

u/ml

1.53

209

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.94

3.57

1.1

1.0

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.98

3.40

1.3

282.21

331.11

umol/24h

0.32

(3017937) Magnesium [Moles/time] in 24 hour Urine

5.00

3.36

1.1

1.3

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

5.72

3.34

1.4

1.0

197.50

290.78

u/ml

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

527

1.52

3.24

1.1

1.2

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.58

3.20

1.1

101.65

101.33

titre

0.00

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

4.17

3.19

1.0

1.1

0.06

0.03

u/ml

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.27

3.18

3.3

2.7

0.68

0.56

u/field

0.21

(3041672) Baker's yeast Ab [Presence] in Serum

2.68

3.05

1.0

1.1

—

(40768800) Prostate Pathology biopsy report

176

2277

0.77

3.02

1.2

—

(3025130) Human papilloma virus identified in Specimen

139

1030

1.35

3.01

1.9

1.8

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

10.00

2.98

1.0

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

10.00

2.98

1.0

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

3.85

2.97

1.0

1.1

0.01

0.05

u/ml

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

329

2721

1.22

2.97

2.7

1.6

8.40

4.16

mg/l

3.73

284

1990

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

3.44

2.89

1.2

1.00

1.10

u/field

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

4.09

2.88

1.9

2.1

269.54

301.68

ug/l

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

4.45

2.79

1.0

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

143

1082

1.33

2.73

1.1

2.18

3.68

eliau/ml

1.33

458

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.71

1.1

—

(3018291) Platelet Ab [Presence] in Serum

6.00

2.69

1.0

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

3.06

2.56

2.0

1.5

0.67

0.33

u/l

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

2.42

2.53

1.0

1.1

26.09

27.45

u/ml

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

2.42

2.53

1.0

1.1

62.00

25.51

u/ml

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

268

3232

0.82

2.52

1.6

998.28

999.41

mu/l

0.01

221

2750

(3001729) Color of Synovial fluid

2.27

2.50

1.9

1.5

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

137

1.90

2.45

1.5

1.1

22.25

20.24

mmol/l

1.00

121

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

2.17

2.40

1.1

—

(3009015) Lactate [Moles/volume] in Synovial fluid

2.17

2.40

1.1

1.2

7.50

5.38

mmol/l

—

(3009677) Dengue virus Ab [Presence] in Serum

3.34

2.39

1.2

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

376

1.52

2.39

1.7

123.28

372.75

pmol/l

0.53

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1207

11112

1.10

2.38

5.5

5.0

33.21

32.91

0.39

921

7179

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

102

752

1.36

2.36

2.8

5.3

122.39

78.03

u/ml

0.31

244

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

2.61

2.35

18.9

7.5

—

(3007700) Barley IgE Ab [Units/volume] in Serum

3.03

2.35

1.0

1.1

0.36

1.65

u/ml

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

128

1658

0.77

2.30

1.5

—

(3005033) Fetal Nuchal fold Thickness US

102

1362

0.75

2.29

1.5

1.18

1.27

1.42

991

(3006567) Chloride [Moles/time] in 24 hour Urine

3.89

2.25

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

106

1.98

2.25

1.4

1.6

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

5.56

2.21

1.0

1.1

0.40

1.67

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

128

1.88

2.20

2.3

1.7

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

2.13

2.18

1.2

1.0

27.00

17.29

iu/ml

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

132

1684

0.78

2.13

1.5

1.24

1.21

ratio

0.17

1018

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

132

1684

0.78

2.13

1.5

0.91

0.95

ratio

0.70

1010

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

2.37

2.11

1.3

1.6

0.58

3.40

u/ml

1.30

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

132

1681

0.78

2.11

1.5

1.27

1.15

ratio

0.52

1007

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

167

1.74

2.10

1.1

1.7

1.98

1.90

ug/l

0.09

(3047352) Trisomy 18 risk [Likelihood] in Fetus

106

1388

0.76

2.10

1.5

—

(1617658) Protocol used for examination of sentinel lymph nodes

582

0.63

2.07

1.1

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

5.00

2.07

1.0

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

5.00

2.07

1.0

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

109

1417

0.77

2.06

1.6

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

200

1.65

2.01

1.5

1.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

239

1.59

2.00

1.0

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

4.55

1.94

2.2

22.32

25.33

—

(42528597) U1 small nuclear ribonucleoprotein C Ab [Presence] in Serum by Line blot

4.55

1.94

1.0

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

4.55

1.94

1.0

1.3

—

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

4.55

1.94

1.0

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.31

1.87

1.4

1.2

—

(3036180) Methadone [Presence] in Urine

4.17

1.82

3.0

2.1

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.76

1.79

1.3

1.2

214.01

33.68

umol/24h

—

(40768793) Breast Pathology biopsy report

160

1950

0.82

1.78

1.3

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

2.22

1.73

1.0

1.1

—

(3002719) Hemoglobin [Mass/volume] in Urine

3.85

1.71

1.0

1.2

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

196

1644

1.20

1.68

1.5

1.4

154.82

194.64

pmol/l

0.73

186

1592

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

3.16

1.66

1.0

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

148

1801

0.82

1.64

1.5

64.71

60.49

ug/l

0.41

119

1516

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

376

1.41

1.64

1.0

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

180

2120

0.85

1.44

1.5

1.4

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.73

1.43

1.0

—

(4034850) Laboratory test

320

2831

1.13

1.42

17.2

10.7

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

246

1.46

1.39

1.1

1.0

5.84

12.56

u/ml

1.94

153

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

2.41

1.39

1.6

1.2

203.00

103.00

ug/l

—

(3020874) Milk IgE Ab [Units/volume] in Serum

485

1.32

1.37

1.1

1.32

2.27

u/ml

0.41

172

(3046904) Somatotropin [Units/volume] in Serum or Plasma

2.94

1.36

4.4

1.2

5.02

2.05

mu/l

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.87

1.34

1.1

1.2

1.95

1.66

umol/24h

0.78

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

112

915

1.23

1.32

1.5

1.4

4.02

3.90

ug/l

0.06

827

(40763590) HLA-DQ beta [Type]

2.50

1.30

1.0

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

183

1568

1.17

1.29

1.2

1.1

4.13

4.98

u/ml

0.44

113

854

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.84

1.29

1.1

1.2

0.50

0.29

u/ml

0.17

(46236302) HLA-C [Type] by High resolution typing

2.40

1.24

1.0

—

(3034092) Cytoplasmic Ig cells/cells in Blood

108

1.67

1.22

13.9

8.4

0.53

0.22

1.02

108

(3014133) Dog dander IgE Ab [Units/volume] in Serum

147

1245

1.18

1.21

1.1

6.36

4.21

u/ml

0.65

634

(3023436) Glucagon [Mass/volume] in Serum or Plasma

1.93

1.16

2.2

1.9

294.64

194.14

ng/l

0.48

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

117

1397

0.84

1.15

1.9

1.8

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

2.50

1.15

1.2

25.00

34.15

mg/24h

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

206

1801

1.15

1.2

1.1

2.04

1.86

u/ml

0.12

130

992

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

380

0.68

1.14

1.2

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.75

1.12

1.1

—

(3020650) Glucose [Presence] in Urine

305

1.35

1.04

1.6

1.7

0.07

0.02

estimate

0.32

305

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

2.27

1.03

2.0

1.0

3.00

3.55

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

180

1.45

1.00

1.1

1.2

1.59

12.80

u/ml

1.71

120

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

2.00

1.00

1.1

1.2

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

475

1.26

0.99

1.1

0.97

2.88

u/ml

1.20

137

(4094501) Cardiovascular stress test using bicycle ergometer

270

2431

1.11

0.98

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

136

1171

1.16

0.97

1.1

6.10

5.78

u/ml

0.07

537

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1185

11316

1.05

0.94

1.6

1.5

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

433

0.74

0.94

1.5

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

427

1.27

0.92

1.1

0.15

2.42

u/ml

1.06

125

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.82

0.92

7.8

5.8

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

1.63

0.90

1.1

1.0

0.01

0.15

u/ml

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

106

1232

0.86

0.83

1.5

1.6

62.11

59.61

ug/l

0.22

106

1232

(3001556) Androgen free Index in Serum or Plasma

1.64

0.81

1.7

1.2

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

182

1.37

0.77

1.1

28.35

42.48

iu/ml

0.43

182

(4133840) Spirometry

209

1.34

0.75

1.2

1.1

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.84

0.73

1.0

1.3

258.34

300.13

nmol/l

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.64

0.73

1.0

1.1

—

(40760410) HLA-B [Type] by High resolution

2.00

0.72

1.0

—

(3013862) HLA-DP [Type]

2.00

0.72

1.0

—

(40760409) HLA-A [Type] by High resolution

2.00

0.72

1.0

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

223

2030

1.10

0.72

1.5

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.52

0.72

1.5

1.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

169

1518

1.12

0.71

1.1

0.71

0.91

u/ml

0.41

700

(46235168) Fasting glucose [Moles/volume] in Blood

109

1.47

0.70

14.8

1.5

7.26

7.72

mmol/l

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.92

0.70

1.0

1.10

2.28

u/ml

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

169

1.36

0.69

3.3

2.7

103.57

110.49

ng/l

0.09

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.85

0.68

1.0

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

338

1.24

0.67

1.0

1.1

15.28

6.36

u/ml

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

161

1456

1.11

0.62

1.2

1.1

2.03

1.68

u/ml

0.24

103

770

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

120

1068

1.12

0.61

1.1

1.11

0.45

u/ml

0.59

362

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

100

884

1.13

0.58

1.4

1.3

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.57

0.56

1.0

8.56

6.76

u/ml

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

910

0.88

0.54

1.2

1.3

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.46

0.46

1.0

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

266

0.79

0.46

2.2

1.5

0.49

0.52

e9/l

0.21

266

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

1085

0.90

0.45

1.3

7.55

7.42

mmol/l

0.17

944

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

142

1540

0.92

0.43

1.7

1.6

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.43

0.42

1.0

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

397

1.16

0.41

1.5

1.3

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.41

0.0

1.2

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1947

19832

0.98

0.40

3.1

3.4

0.79

0.80

ug/l

0.03

1403

13510

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

1.47

0.40

1.2

1.3

1.50

1.31

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

337

1.16

0.36

1.9

0.77

2.91

u/ml

1.43

107

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.30

0.31

1.2

1.0

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

343

0.87

0.27

1.2

12.10

9.99

mm/h

0.34

343

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

193

0.83

0.26

1.3

1.1

82.71

62.58

u/ml

0.37

186

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.67

0.25

1.0

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

1.23

0.25

1.4

1.6

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.17

0.24

1.4

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

231

2399

0.96

0.22

1.7

1.4

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

0.21

0.0

1.2

—

70.72

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.1

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.21

0.0

1.1

—

(3020934) Sesame Seed IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.0

—

0.29

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

355

1.10

0.20

1.4

1.5

23.55

34.97

nmol/l

1.17

316

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

1.20

0.19

1.0

—

(3051101) Glucose [Moles/volume] in Cord blood

186

0.86

0.19

4.7

6.6

9.55

8.13

mmol/l

1.27

186

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

615

0.94

0.14

1.3

131.76

184.60

pmol/l

1.86

615

(40762814) Titanium [Mass/volume] in Blood

171

0.88

0.14

2.1

2.4

3.43

3.40

ug/l

—

(3029396) Erythrocyte agglutination [Presence] in Blood

189

0.90

0.12

3.5

3.0

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

1.04

0.09

1.0

1.1

0.87

1.33

mom

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

1.12

0.07

1.0

1.1

0.01

1.53

u/ml

—

(3006598) pH of Arterial cord blood

103

0.87

0.06

1.0

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

111

0.90

0.06

1.3

55.80

70.44

ug/l

—

111

(4211845) Urine protein measurement

486

1.03

0.04

3.4

3.3

—

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

915

0.98

0.03

4.6

2.8

13.45

13.18

1.23

903

(1002224) Polysomnography panel

354

3564

0.99

0.03

1.1

—

(3006462) Nitrate [Presence] in Urine

443

1.02

0.01

3.3

3.4

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

515

1.01

0.00

4.2

6.8

50.89

95.36

ug/l

0.42

339

(3025577) Chromium [Mass/volume] in Blood

599

1.00

0.00

2.2

1.62

2.27

ug/l

1.71

497

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

158

1.01

0.00

5.6

6.1

13.44

8.01

1.42

158

(40761995) Spermatozoa Progressive [#/volume] in Semen

158

1.01

0.00

2.8

3.0

39.25

45.77

0.53

158

(44806420) Estimation of glomerular filtration rate

863

1.00

0.00

3.2

2.5

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

0.0

1.2

—

36.70

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.0

1.1

—

0.28

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

1.02

0.00

1.0

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(40762887) Creatinine [Moles/volume] in Blood

1.01

-0.00

1.6

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

-0.00

0.0

1.0

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

-0.00

0.0

1.0

—

6927.63

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: AB1_SEPSIS_VIRAL_IMPL – Implicit viral Sepsis

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Implicit viral Sepsis

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Implicit viral Sepsis (AB1_SEPSIS_VIRAL_IMPL)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints